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ABSTRACT 
 
 Neuropeptide signaling play critical roles in maintaining distinct behavioral states 
and orchestrating transitions between them. However, elucidating the mechanisms 
underlying neuropeptide modulation of neural circuits in vivo remains a major challenge. 
The nematode Caenorhabditis elegans serves as an excellent model organism to study 
neuropeptide signaling mechanisms encoded in relatively simple neural circuits. We have 
used the C. elegans egg-laying circuit as a model to understand how neuropeptide 
signaling modifies circuit activity to generate opposing behavioral outcomes. C. elegans 
egg-laying behavior is composed of alternating cycles of two states – short bursts of egg 
deposition (active phases) and prolonged periods of quiescence (inactive phases). We 
have identified two neuropeptides (NLP-7 and FLP-11) that are locally released from a 
group of neurosecretory cells (uv1) and coordinate the temporal organization of egg-
laying by prolonging the duration of inactive phases. These neuropeptides regulate 
activity within the core circuit by inhibiting serotonergic transmission between its individual 
components (HSN motorneurons and Vm2 vulval muscles). This inhibition is achieved at 
least in part, by reducing synaptic vesicle abundance in the HSN synaptic regions. To 
identify potential downstream signaling components that mediate the actions of these 
neuropeptides, we have performed a forward genetic screen and have identified a strong 
candidate. In addition, we are trying to identify the receptor(s) of these neuropeptides by 
using a candidate gene approach. Together, we demonstrate that local neuropeptide 
signaling maintains the periodicity of distinct behavioral states by regulating serotonergic 
transmission in the core neural circuit.  
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CHAPTER I: INTRODUCTION 
 
 
 
 
 
 
 
 
 
“We are part of nature, a product of a long evolutionary journey. To some degree, we 
carry the ancient oceans in our blood. … Our brains and nervous systems did not 
suddenly spring into existence without long antecedents in natural history. That which we 
most prize as integral to our humanity - our extraordinary capacity to think on complex 
conceptual levels - can be traced back to the nerve network of primitive invertebrates, the 
ganglia of a mollusk, the spinal cord of a fish, the brain of an amphibian, and the cerebral 
cortex of a primate.” 
 
- Murray Bookchin 
 Defending the Earth: A Dialogue Between Murray Bookchin and Dave Foreman 
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Composition of animal behavior 
 
Animal behaviors are often temporally organized into distinct alternating states. 
Transitions between these component states or modifying their duration provides a facile 
mechanism to improve their chances of survival and reproductive success. At the 
appropriate time, animals must either continue with a particular phase of behavior or 
switch to a different phase. This can be triggered by a variety of environmental conditions 
or by internal homeostatic cues. For example, many foraging animals alternate between 
periods of active foraging spells and migration between feeding sites (Owen-Smith et al., 
2010). The timing and duration of feeding and migration depends both on external factors 
such as food availability and quality, risk of predation and internal states such as 
metabolic costs or arousal levels. High quality of food during spring leads to animals 
spending shorter foraging times that alternates with longer periods of food search 
whereas low food quality during dry summer season ensures longer foraging spells 
interspersed by shorter search intervals (Heitschmidt and Stuth, 1991) (Figure I-1). 
Transitions between behavioral states can also be probabilistic and can occur without any 
trigger stimuli. For example, freely behaving mice in home cages typically alternate 
between active states characterized by feeding and patrolling and inactive states of rest 
and sleep (Goulding et al., 2008). A key strategy for survival relies on animals being able 
to rapidly modify the timing and duration of component behavioral states in response to 
changes in the environment as well as internal physiology.   
 Behavioral states have been shown to be associated with distinct patterns of 
activity in specific regions of the mammalian brain. For example, in vivo recordings from 
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neocortex in mice have revealed state-dependent changes in network activity associated 
with sleep-wake behavioral pattern. During sleep, there is a predominance of slow waves 
representing Up and Down states in the local network. Transition to wakefulness is 
associated with termination of Down states and enhancement of higher frequency 
rhythms (Zagha and McCormick, 2014) (Figure I-2A). Behavioral states are also shown 
to be correlated with global changes in activity in the human brain. fMRI studies have 
revealed changes in functional connectivity across different brain regions in bipolar 
disorder patients undergoing distinct mood states – mania and euthymia (Brady Jr. et al., 
2016) (Figure I-2B).         
 All behaviors ranging from simple reflexes to sleep, mood, and higher cognitive 
tasks result from the activity of neural circuits within the nervous system. How do neural 
circuits coordinate transitions between behavioral states and maintain their duration for 
appropriate time intervals? In addition, how do neural circuits alter their activity patterns 
in response to changes in external conditions and internal cues to modify the duration of 
component behavioral states? Understanding the cellular mechanisms and identifying the 
molecular candidates involved in altering neural circuit activity and establishing distinct 
behavioral states remains one of the major challenges in neurobiology.    
 
Neuromodulation of behavior 
 How are alternating behavioral states encoded within anatomically hardwired 
neural circuits? The first idea came from early studies in the mollusc Tritonia, which 
demonstrated that the same network of neurons could generate alternating behavioral 
paradigms – a defensive withdrawal reflex and an escape swimming response (Getting 
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and Dekin, 1985). These studies raised the intriguing possibility that neural circuits may 
display an inherent functional flexibility that allow them to adapt to changing conditions. 
The most detailed analysis of potential mechanisms underlying such flexibility within 
neural circuits came from studies on the crustracean stomatogastric ganglion (STG). It is 
a motor circuit comprising of ~30 neurons associated with rhythmic feeding behavior. Two 
sub-circuits within the STG motor circuit generate distinct rhythmic outputs – the faster 
pyloric rhythm (once every second) and the slower gastric rhythm (every 5-10 seconds). 
The functioning of the neurons involved in generating these two different rhythms are not 
strictly dependent on their anatomical connectivity within their respective sub-circuits. 
Neurons within the pyloric circuit can switch inputs to join the gastric circuit and vice-versa 
or change their firing patterns in a context-dependent manner (Weimann and Marder, 
1994; Hooper and Moulins, 1989).            
 The molecular candidates that orchestrate reconfiguration of circuits or activity 
changes within circuit components has been largely attributed to a class of molecules 
called neuromodulators. In contrast to classical neurotransmitters that are released at 
synaptic sites and act on fast-acting ionotropic receptors, neuromodulators are largely 
secreted in a hormonal fashion and may act either locally or may travel long distances to 
act on distant target cells (Figure I-3). In a majority of cases, the receptors that mediate 
the actions of neuromodulators are G-protein coupled receptors (GPCRs). GPCRs have 
slower kinetics of action compared to ionotropic receptors and have much longer lasting 
effects. As a result, neuromodulatory signaling is more suited to generate and maintain 
long-lasting behavioral states. In several studies, neuromodulators have been reported 
to establish distinct behavioral states and mediate transitions between them. For 
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example, several neuromodulators such as acetylcholine (ACh), norepinephrine (NE), 
serotonin (5-HT), histamine (HA), and glutamate (Glu) have been implicated in the 
transition from sleep to wakefulness in mice (Figure I-2). Neuropeptides constitute the 
largest class of neuromodulators and have been reported to establish distinct behavioral 
states. For example, the agouti-gene related neuropeptide have been shown to promote 
feeding behavior (Aponte et al., 2011). In addition, vasopressin has been demonstrated 
to play critical roles in decision-making that underlies social behavior (Pitkow et al., 2001).   
 To decipher neuromodulatory effects on neural circuits and behavior, it is critical 
to understand the mechanisms of neuromodulation at the systems, cellular and molecular 
levels.  
 
Mechanisms of neuromodulation 
 
Studies in invertebrates such as lobster and Aplysia have shed light on how 
neuromodulatory signaling alter the functioning of neural circuits. The principles of 
neuromodulation are complex – single modulators may exert their effects on multiple 
neurons and activities of multiple channels or single neurons may be modulated by 
several neuromodulators. The two major mechanisms by which neuromodulators modify 
the functional connectivity of neural circuits are by (1) modulation of synapses and (2) 
modulation of neuronal excitability.  
 One simple mechanism of synapse modulation is modification of synaptic strength. 
Neuromodulators can either strengthen or weaken synaptic transmission between 
components within a circuit according to behavioral needs (Figure I-3A). For example, 
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serotonin can functionally silence synapses in the crustracean STG, while dopamine can 
unmask normally silent synapses (Johnson et al., 1994). 
 Neuromodulators can also change synaptic dynamics within a circuit. Modulation 
of short-term synaptic plasticity (STP) can act as a gain-control mechanism leading to 
changes in synaptic strength in response to repetitive presynaptic activity (Rothman et 
al., 2009; Abbott et al., 1997) (Figure I-3A). Studies on the Aplysia gill and siphon reflex 
in response to touch stimulus have shed light on neuromodulatory effects on synaptic 
dynamics (Hawkins et al., 2006). The functional sensorimotor connectivity responsible for 
the reflex action normally habituates but is sensitized by serotonin signaling triggered by 
pairing touch with a noxious tail shock. Serotonergic modulation leads to increase in the 
width of presynaptic action potential and enhanced neurotransmitter release (Kandel, 
2001; Klein et al., 1982).  
 Responses to presynaptic inputs or intrinsic activity within neurons critically 
depend on the presence of ion channels that regulate neuronal excitability. Early studies 
have shown that neuromodulators may alter the gating properties of voltage-gated ion 
channels (Kaczmarek and Levitan, 1986) and also sometimes, change their unitary 
conductances (Pfeiffer-Linn and Lasater, 1996). In this way, neuromodulators can have 
profound effects on membrane excitability of neurons. Neuromodulatory effects on 
membrane excitability may be straightforward or more complex. For instance, 
neuromodulators may either alter excitability to lead to a linear increase or decrease of 
activity or may give rise to distinct patterns of activity by effecting excitability in a non-
linear fashion (Figure I-3B). The classical mechanism of neuromodulation of ion channels 
can be attributed to binding of neuromodulators to G-protein coupled receptors which in 
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turn activate second messengers triggering the action of kinases and phosphatases that 
modify ion channel proteins. However, other pathways may also contribute such as direct 
gating by cyclic nucleotides (Podda and Grassi, 2013; He et al., 2014) or G proteins 
(Dascal, 2001), or direct and indirect effects of tyrosine kinases (Ahn et al., 2007; Lee et 
al., 2013). Different neuromodulators can affect distinct ion channels in the same neurons 
or different modulators can have converging effects on the same channel. 
Neuromodulators may also modify the properties of other types of channels. For instance, 
the two-pore domain K+ channels involved in leak conductance in many neurons are 
subject to modulatory effects (Talley et al., 2000).  
 Modifications of circuit dynamics and circuit composition by synaptic modulation 
and altering neuronal excitability by neuromodulators allows for adaptability of circuit 
functioning in different behavioral contexts. 
 
Challenges in studying neuromodulatory effects on behavior 
 
 Several well-demonstrated studies in higher organisms have indicated that 
neuromodulators can have profound effects on behavioral outcomes and play critical 
roles in establishing stable behavioral states. Neuromodulators have also been implicated 
in mediating the transition between opposing behavioral phases. However, the complexity 
of neural circuits in vertebrates and mammals have limited the quest for decoding the 
underlying mechanisms responsible for neuromodulation of circuits.  
 Remarkable progress has been made by investigating neuromodulatory 
mechanisms in the context of relatively simple neural circuits of crustaceans and 
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mollusks. Although such systems offer several technical advantages, most studies have 
been performed using dissected specimens and isolated neurons. In addition, such 
studies have relied on application of exogenous neuromodulators. 
 One of the major challenges in the field is to bridge the gap between 
neuromodulatory action on circuits in vivo and the generation of distinct behavioral states. 
It is critical to investigate the action of neuromodulators on neural circuits where they are 
endogenously released and dissect neuromodulatory mechanisms in intact freely 
behaving animals. Such studies would enable us to link in vivo activation of specific 
neuromodulatory signaling pathways with corresponding behavioral outcomes.  
            
Caenorhabditis elegans 
 
Over the past few decades, C. elegans has served as an excellent model organism for 
advancing the field of neurobiology. It is easy to maintain under laboratory conditions and 
has a short life-cycle of 3 days. It has a relatively simple nervous system consisting of 
302 neurons and the anatomical connectivity of its nervous system has been fully 
elucidated by serial-electron microscopy (White et al., 1986). It is also amenable to 
powerful genetic analysis and this coupled to a short generation time, enables rapid 
production of transgenic animals and experimental analysis. C. elegans has a transparent 
cuticle that allows fluorescent imaging and optogenetics in intact living animals. 
Additionally, several molecular candidates and signaling pathways are conserved in 
higher organisms.  
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 Even with a simple nervous system, C. elegans exhibits a diverse range of 
behaviors ranging from simple motor behaviors like feeding, locomotion, egg-laying to 
sensory behaviors like chemosensation and mechanosensation. The known anatomical 
connectivity of its nervous system coupled with ease of genetic manipulations enables 
dissection of behaviors at the cellular and molecular level.  
 
Neuropeptide signaling in C. elegans 
 
The C. elegans genome harbors approximately 119 neuropeptide precursor genes and 
encodes a vast array of about 265 neuropeptides. These are subdivided into three major 
families depending on the presence of conserved sequence motifs. The first family 
constitutes the FMRFamide-like peptide (flp) gene family that consists of 70 different 
peptides encoded by 33 precursor genes. The second family comprises about 40 insulin-
like peptides (ins) encoded by 40 precursor genes. The third family consists of peptides 
without sequence similarity to either FMRFamide or insulin-like peptides, and are called 
neuropeptide-like proteins (nlp). This consists of the largest group of about 155 
neuropeptides encoded by 46 precursor genes (Janssen et al., 2010).  
 Similar to mammals, mature neuropeptides in C. elegans are generated by 
posttranslational processing and modification of precursor molecules. Typically, the 
neuropeptide precursor is cleaved C-terminal to mono, di, or tribasic residues by 
proprotein convertase enzymes (EGL-3 / KPC-2). Basic amino acids are eliminated by 
carboxypeptidases E (EGL-21) to generate pro-neuropeptides. These are further 
modified by addition of specific motifs (such as amide groups) to yield mature peptides. 
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These active peptides are stored in dense-core vesicles which may be released either at 
synaptic sites or extrasynaptically in a humoral fashion. Several proteins have been 
reported to be involved in the transport and release of dense-core vesicles. These include 
the motor protein UNC-104, the calcium-dependant activator protein UNC-31, the protein 
kinase I PKC-1, and the protein tyrosine phosphate-like receptor IDA-1. (Hall and 
Hedgecock, 1991; Zahn et al., 2004; Sieburth et al., 2007). 
 Neuropeptide signaling have been demonstrated to modulate several different 
behaviors in C. elegans. One of the most well-studied examples is the food-related 
aggregation behavior. Some wild type strains forage on a bacterial lawn in a solitary 
fashion whereas others clump together into aggregates. Neuropeptide signaling mediated 
by FLP-21 peptides and its receptor NPR-1 have been reported to promote solitary 
feeding and inhibit social feeding (de Bono and Bargmann, 1998). Another example 
comes from neuropeptide modulation of food search behavior. When wild type worms are 
removed from food, they undergo an exploratory behavior in search of food. This behavior 
is characterized by an increase in the number of high angle body bends and orientations 
to maximize the chances of finding food in the local environment. This phase of 
exploratory behavior is mediated by neuropeptides encoded by the nlp-12 gene and nlp-
12 mutants are defective in food search (Bhattacharya et al., 2014).  
 Thus, C. elegans can be an useful model to study the modulatory actions of 
neuropeptides in vivo and deciphering their specific effects on neural circuits where they 
are endogenously released.    
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C. elegans egg-laying behavior 
  
 C. elegans are self-fertile hermaphrodites producing their own sperm and oocytes 
that undergo internal fertilization to produce embryos. Embryos are stored in the uterus 
and typically a wild type animal retains around 15 eggs in utero. Specialized sex-specific 
muscles contract to open the vulva and allow successful deposition of eggs. Under 
favorable conditions, egg-laying behavior displays a specific temporal pattern. Typically, 
the animal stochastically alternates between two distinct behavioral states - short bursts 
of egg-laying (active phase) ranging from 1 – 5 minutes in duration and prolonged periods 
of quiescence (inactive phase) of about 20 minutes on average (Figure I-5B, C).  
 The exact reason(s) for maintaining such a temporal organization of egg-laying is 
largely unclear although several reasons can be speculated. First, after fertilization, 
animals typically retain their eggs in utero until they reach a certain threshold of 
multicellular development (usually >20 cell stage embryos). Arresting egg-laying activity 
for long periods may allow the eggs to reach the threshold and thus prevent exposure of 
premature embryos in the environment. Second, this temporal pattern of egg-laying may 
allow spatial dispersal of eggs and prevent local overcrowding and competition for food.  
 C. elegans has the ability to dramatically alter its rate of egg-laying in response to 
changes in the environment. Egg-laying activity reduces significantly in the absence of 
food (Trent, 1982). Similarly, mechanical stimulation, high osmolarity of the medium and 
high levels of carbon-dioxide have been shown to reduce egg-laying rates (Sawin, 1996; 
Horvitz, 1982; Fenk and de Bono, 2015).     
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 Thus, the temporal organization of egg-laying behavior into two opposing 
behavioral states and its sensitivity to changes in external context provide a useful model 
to study neuromodulatory control of behavior. 
 
Anatomy and functional connectivity of the C. elegans egg-laying circuit   
  
 C. elegans egg-laying is controlled by a relatively simple neuromusculature and 
the anatomical connectivity between its components has been elucidated (Figure I-6A, 
B). A total of sixteen muscles are likely involved in the control egg-laying but of them, the 
four vm2 vulval muscles are the most critical. They are arranged in a cross-shape with 
their apical ends attached to the vulva and are electrically coupled to each other by gap 
junctions. They are the only muscles receiving significant synaptic input from neurons and 
their ablation leads to complete termination of egg-laying suggesting that they play a 
critical role in vulval contraction during egg-laying. The vm2 muscles are electrically 
coupled to vm1 class of vulval muscles. These muscles do not receive significant synaptic 
input and also do not dramatically alter egg-laying when ablated. There are also eight 
uterine muscles surrounding the anterior and posterior arms of the uterus. These muscle 
are believed to constrict the uterus during egg-laying thereby pushing eggs out of the 
vulva. Ablation of these muscles do not result in any obvious changes in egg-laying. Two 
hermaphrodite-specific neurons (HSNs) are critical for regulating egg-laying behavior. 
The HSN cell bodies are located posterior to the vulva and extend a process ventrally into 
the ventral nerve cord and then anteriorly towards the nerve ring. At close proximity to the 
vulva, the HSNs make synapses with the vm2 vulval muscles. The HSNs promote egg-
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laying at least in part, by releasing serotonin (Horvitz, 1982; Desai, 1988), although it may 
also use acetylcholine (Duerr, 2001) and one or more neuropeptides (Schinkmann and 
Li, 1992; Kim and Li, 2004). Six VC motorneurons in the ventral nerve cord can be 
subdivided into two groups – vulval-proximal VC4 and VC5, and vulval-distal VC1-3 and 
VC6. VC4 and VC5 exclusively make synapses with the vulval muscles and other VCs. 
The other VCs make fewer synapses with the vulval muscles than VC4 and VC5, but 
direct synaptic output to the body wall muscles and the D-class GABAergic motorneurons. 
The VCs are cholinergic (Duerr, 2001) and also express at least RFamide peptide 
(Schinkmann and Li, 1992). They also stain weakly for serotonin but do not express the 
serotonin biosynthesis enzyme tryptophan hydroxylase suggesting that they may locally 
reuptake serotonin from neuromuscular junctions between the HSNs and vulval muscles. 
The role of VCs in regulating egg-laying has not been unambiguously elucidated but 
several evidences suggest that they may be involved in vulval muscle contraction by 
cholinergic signaling mediated by acetylcholine receptors expressed in vulval muscles 
(Trent et al., 1983; Weinshenker et al., 1995; Waggoner et al., 2000).  
 Another group of cells known as uv1 cells do not make synapses with the rest of 
the egg-laying circuit, and are located at the junction between the uterus and the vulval 
epithelium, in close proximity to the egg-laying neuromusculature. These cells appear to 
function as neurosecretory cells and express the neuromodulator tyramine and the 
FMRFamide class of neuropeptides (Alkema, 2005; Kim and Li, 2004). The exact role of 
the uv1 cells in regulating egg-laying is largely unclear. The expression of candidate 
neuromodulators indicates that uv1 cells may play an important role in the temporal 
control of egg-laying.  
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 The simplicity of the neuromusculature and anatomical connectivity of the egg-
laying circuit would potentially serve as a good system to study the role of neuropeptides 
in modulating circuit activity and generating alternating behavioral outcomes.           
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Figure I-1: Distinct behavioral states of foraging behavior  
 Effects of seasonal quality of plants on feeding behavior of herbivores. High quality of 
food in spring ensures shorter feeding times at foraging sites (FS) with longer periods of 
search between foraging sites. Conversely, low plant quality in dry summer season 
prolongs feeding times at foraging sites and reduces search intervals between sites. 
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Figure I-2: Distinct patterns of brain activity correlate with different behavioral 
states. (A) State-dependent changes in activity within the cortex in mice. Slow wave sleep 
is associated with slow waves in the EEG and occurrence of Up and Down states in the 
local cortical field. Transition to wake state is accompanied by abolition of Down states 
and an increase in higher frequency rhythms (gamma waves). Several neuromodulators 
have been implicated in this transition. (B) Differences in whole brain functional 
connectivity in bipolar disorder patients undergoing bipolar mania vs bipolar euthymia. 
Each inset shows the regions of interest (ROIs) showing significant difference in 
functional connectivity in mania vs euthymia. 
A 
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Figure I-3: Comparison of fast-acting neurotransmitters and slow-acting 
neuromodulators.  Neurotransmitters are packaged in synaptic vesicles, released at 
synapses and act locally on ionotropic receptors. Neuromodulators such as 
neuropeptides, are typically packaged into dense-core vesicles which may act locally or 
may travel over long distances to act on G-protein coupled receptors to mediate their 
effects.   
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Figure I-4: Mechanisms of neuromodulation. (A) Neuromodulators can affect synaptic 
strength by modifying response to a single presynaptic input (left gray box) or short-term 
synaptic plasticity by modulating responses to sustained presynaptic inputs (right gray 
box). (B) Neuromodulators may modify membrane excitability either in a straightforward 
manner (modulator 1) or in a complex non-linear fashion (modulator 2). 
 
 
A 
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Figure I-5: C. elegans egg-laying is composed of distinct behavioral states. 
(A) Cartoon showing the opposing phases of egg-laying behavior. Egg-laying activity is 
composed of alternating cycles of active and inactive phases. (B) Temporal organization 
of egg-laying behavior. Typically, under laboratory conditions, short bursts of egg-laying 
activity (active phases) are interspersed with prolonged periods of quiescence (inactive 
phases).  
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Figure I-6: Anatomy and connectivity of the C. elegans egg-laying circuit.  
(A) Anatomy of the egg-laying neuromusculature (Schafer, 2006). See text for details. (B) 
Schematic showing connectivity within components of the egg-laying circuit. The HSNs 
make synaptic connections onto Vm2 vulval muscles and the VC5 motor neurons. 
Serotonin release from the HSNs is required for egg-laying. Cholinergic VC4 and VC5 
motor neurons make synaptic connections onto the vulval muscles. The VCs might also 
inhibit the HSNs through putative extrasynaptic signaling. The synaptic connections of 
VCs onto muscle are primarily excitatory. Neurosecretory uv1 cells express several 
neuromodulators with potential for regulating egg-laying activity but do not have direct 
postsynaptic targets. Circles represent putative inhibitory connections while arrows 
denote excitatory connections. Solid lines depict known synaptic connections while 
dashed lines depict putative extrasynaptic signaling. Connections based on Collins and 
Koelle, 2013; Schafer, 2006; White et al., 1986; Zhang et al., 2008.  
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Thesis outline 
 
 This thesis demonstrates how neuromodulatory signaling mechanisms are 
encoded within a neural circuit in vivo to generate a specific temporal pattern of behavior. 
The model system I used here is the egg-laying behavior of the nematode C. elegans. 
Egg-laying behavior of C. elegans follows a temporal organization where the animal 
typically undergoes alternating cycles of two distinct behavioral states – short bursts of 
active egg-laying (active phase) followed by prolonged periods of quiescence (inactive 
phase). While the connectivity of the circuit and the molecular signals responsible for 
successful deposition of eggs is well characterized, the mechanisms governing the 
temporal pattern of egg-laying remain unclear.    
 In Chapter II, we demonstrate that altering the activity of a group of neurosecretory 
cells (uv1) located in close proximity to the egg-laying neuromusculature, results in 
disruption of the timing of egg-laying events. We also identify two neuropeptides (NLP-7 
and FLP-11) that are expressed in the uv1 cells and are required for the modulatory 
effects of uv1 cells on egg-laying behavior. By monitoring egg-laying activity in freely 
behaving animals, we show that these neuropeptides synergistically inhibit egg-laying by 
prolonging the duration of inactive phases. By cell-specific overexpression, we 
demonstrate that local release of NLP-7 and FLP-11 peptides from uv1 cells is required 
for their inhibitory effects. Using a combination of optogenetics, pharmacology as well as 
genetic loss-of-function and gain-of-function tools, we show that NLP-7 inhibits 
serotonergic transmission between the HSNs and vulval muscles. Our imaging results 
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reveal that this inhibition is at least in part, achieved by reducing synaptic vesicle 
abundance in the HSN presynaptic compartment.  
 Neuropeptides typically mediate their effects by binding to G-protein coupled 
receptors (GPCRs). In Chapter III, we make an attempt to identify potential receptor(s) 
and downstream signaling components that are responsible for mediating the inhibitory 
effects for these neuropeptides. Overexpression of NLP-7 (NLP-7 OE) led to robust 
inhibition of egg-laying. We are using a candidate-gene approach using GPCR loss-of-
function mutants to identify suppressors of the egg-laying defect of NLP-7 OE animals. 
Additionally, we have also performed a forward genetic screen to identify genes that may 
act downstream of NLP-7 signaling. We have identified a potential candidate that strongly 
suppresses the NLP-7 OE egg-laying defect. Future experiments would reveal the identity 
of this candidate and its role in neuropeptide signaling.  
 Neuromodulation allows flexibility to structurally hardwired circuits by modifying 
their activity patterns in response to external conditions as well as internal states of the 
animal. In this thesis, I have used the C. elegans egg-laying circuit as an in vivo system 
to demonstrate that local neuromodulation mediated by neurosecretory cells modifies 
neurotransmission within a core circuit to shape the temporal pattern of behavior. This 
thesis also provides insights into potential signaling mechanisms mediated by GPCRs 
that underlie the modulatory actions of neuropeptides. Knowledge of neuropeptide 
signaling mechanisms in simple circuits can be extended to understanding the basis of 
neuromodulatory effects on behavior in more complex systems.    
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PREFACE TO CHAPTER II 
 
 The work presented in this chapter demonstrates how neuromodulators alter the 
activity pattern of neural circuits to shape the temporal organization of behavior. 
Neuromodulatory actions are superimposed on anatomically hardwired circuits to help 
them to adapt and change their firing patterns in response to the changing environment 
or internal physiology. The effects of several neuromodulators allow the same set of 
neurons within a circuit to display alternate activity patterns and thus generate distinct 
behavioral states. In this chapter, we have dissected neuromodulatory signaling 
mechanisms in vivo that regulate the timing of egg-laying behavior in C. elegans. Under 
favorable laboratory conditions, egg-laying activity alternates between two distinct 
behavioral states – short bursts of egg deposition (active phases) followed by prolonged 
periods of quiescence (inactive phases). In this chapter, neuromodulatory signaling 
mediated by two neuropeptides are shown to govern the timing of egg-laying by 
prolonging the duration of inactive phases. These neuropeptides modify the activity of the 
neural circuit responsible for egg-laying by inhibiting serotonergic transmission between 
motorneurons and muscles. This chapter links the in vivo actions of specific 
neuromodulators on circuits where they are endogenously released with the generation 
of opposing behavioral outcomes.  
 Navonil Banerjee performed the behavioral, optogenetic and pharmacological 
experiments and analyzed all data. Michael Gorczyca performed the imaging experiments 
of HSN synapses and cell bodies. Navonil Banerjee and Michael Francis designed the 
experiments and co-wrote the manuscript. Navonil Banerjee, Raja Bhattacharya and 
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Kevin M Collins generated transgenic strains. All authors commented on the manuscript. 
This work was accepted for publication in PLoS Genetics at the time of this thesis 
presentation. 
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Abstract 
Animal behaviors are often composed of distinct alternating behavioral states. 
Neuromodulatory signals are thought to be critical for establishing stable behavioral 
states and for orchestrating transitions between them. However, we have only a limited 
understanding of how neuromodulatory systems act in vivo to alter circuit performance 
and shape behavior. To address these questions, we have investigated neuromodulatory 
signaling in the context of Caenorhabditis elegans egg-laying. Egg-laying activity cycles 
between discrete states–short bursts of egg deposition (active phases) that alternate with 
prolonged quiescent periods (inactive phases). Here using genetic, pharmacological and 
optogenetic approaches for cell-specific activation and inhibition, we show that a group 
of neurosecretory cells (uv1) located in close spatial proximity to the egg-laying 
neuromusculature direct the temporal organization of egg-laying by prolonging the 
duration of inactive phases. We demonstrate that the modulatory effects of the uv1 cells 
are mediated by peptides encoded by the nlp-7 and flp-11 genes that act locally to inhibit 
circuit activity, primarily by inhibiting vesicular release of serotonin from HSN motor 
neurons. This peptidergic inhibition is achieved, at least in part, by reducing synaptic 
vesicle abundance in the HSN motor neurons. By linking the in vivo actions of specific 
neuropeptide signaling systems with the generation of stable behavioral outcomes, our 
study reveals how cycles of neuromodulation emanating from non-neuronal cells can 
fundamentally shape the organization of a behavioral program.  
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Author Summary 
Animals have robust mechanisms in place to shape their behavior in a manner that is 
beneficial both for their survival and for the survival of their progeny. A class of signaling 
molecules known as neuropeptides have been implicated in driving transitions between 
behavioral states but we have only a limited understanding of how neuropeptide signaling 
modulates neural circuit activity in vivo to elicit alternate behavioral outcomes. Egg-laying 
behavior in the model system C. elegans cycles between clusters of egg-laying and 
prolonged inactive periods. This temporal organization provides for spatial dispersal of 
eggs, presumably benefiting progeny by limiting local overcrowding and competition for 
food. Here we uncover a novel neuromodulatory mechanism that shapes the timing of 
egg-laying behavior. Specifically, we find that neuromodulatory signaling from a group of 
non-neuronal cells specifies transitions between active and inactive phases of egg-laying 
by regulating neurotransmitter release from the motor output neurons of the egg-laying 
circuit. Advancing our knowledge of how neuropeptides and other modulators act in the 
context of the circuits in which they are endogenously released will be critical in ongoing 
efforts to understand how alternate behavioral states, for example those underlying mood 
or arousal, are encoded. 
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Introduction 
Animals have robust mechanisms in place to shape their behavior in a manner that is 
beneficial both for their survival and for the survival of their progeny. In many cases 
behaviors are composed from discrete, opposing behavioral states. Examples of 
behaviors that are organized in this manner range from the motor programs underlying 
feeding or locomotion to more complex behaviors such as mood or arousal (Ben Arous 
et al., 2009; Fujiwara et al., 2002; Osborne et al., 1997; Saper et al., 2010; Young and 
Dulcis, 2015) . In each of these cases, animals adapt their behavior in response to either 
changes in environmental conditions or internal physiological signals by modifying the 
duration of component behavioral states. 
How the nervous system establishes the duration of particular behavioral states and 
executes transitions between them, however, is largely unclear. Neuromodulators such 
as neuropeptides are attractive candidates for orchestrating these processes (de Lecea, 
2012; Flavell et al., 2013; Laurent et al., 2015; Waggoner et al., 1998; Waggoner et al., 
2000; Wang et al., 2013). Pharmacological, biochemical, and electrophysiological studies 
have shed light on how neuropeptide signaling can modify the activity of neural circuits 
(Bargmann, 2012; Bargmann and Marder, 2013; Kupfermann and Weiss, 2001; Marder, 
2012; Palmer and Kristan, 2011; Taghert and Nitabach, 2012). Neuropeptide signals 
typically activate or refine patterns of neural activity that are generated from the actions 
of fast-acting transmitters by altering cellular excitability or by modifying the efficiency of 
synaptic communication between neurons. However, precisely linking in vivo activation 
of specific neuromodulatory systems with changes in circuit performance and the 
generation of alternate behavioral outcomes remains a challenge. Uncovering basic 
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principles by which neuromodulators influence circuit activity and behavior in more simple 
systems provides an important framework for tackling similar questions in the mammalian 
brain. In particular, the neural circuit controlling egg-laying behavior in the nematode 
Caenorhabditis elegans provides a relatively simple and experimentally tractable system 
to address these questions. 
Under favorable conditions, C. elegans egg-laying behavior cycles probabilistically 
between two alternative states: active phases containing short bursts of egg-laying and 
prolonged periods of quiescence (inactive phases) (Collins et al., 2016 ; Garcia and 
Portman, 2016; Schafer, 2006; Waggoner et al., 1998). This temporal organization of egg-
laying allows for spatial dispersal of eggs, and may be beneficial for survival of progeny 
by limiting local overcrowding and competition for food. The core circuitry and signaling 
machinery controlling egg-laying is well described, but the mechanisms responsible for 
this temporal organization have remained unclear. Egg-laying occurs when specialized 
sex-specific muscles contract, opening the vulva and allowing for deposition of eggs. Two 
serotonergic hermaphrodite-specific neurons (HSN) and two cholinergic ventral C class 
motor neurons (VC4 and VC5) make excitatory synaptic contacts onto the Vm2 muscles 
(White et al., 1986). Egg-laying active states are associated with serotonin release from 
the HSNs that increases vulval muscle excitability (Figures 1A, 3A) (Hapiak et al., 2009; 
Schafer, 2006; Shyn et al., 2003; Trent et al., 1983; Waggoner et al., 1998). 
Four neurosecretory cells, known as uv1 cells, are located in close proximity to both 
HSN processes and the egg-laying musculature, forming a ring through which eggs pass 
as they exit the uterus and vulva (Newman et al., 1996). The uv1 cells do not form 
synaptic connections with the egg-laying circuitry, but express candidate 
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neuromodulators (e.g. FMRFamide peptides, tyramine), raising the possibility that 
secretion of neuromodulators from the uv1 cells may allow for temporal coordination of 
egg-laying activity (Alkema et al., 2005; Schinkmann and Li, 1992). By linking acute cell-
specific activation to alternate behavioral outcomes, we demonstrate that uv1 secretion 
of neuropeptides encoded by the nlp-7 and flp-11 genes inhibits HSN-vulval muscle 
transmission, setting the duration of inactive phases during egg-laying. Unlike the other 
neurotransmitter systems described to date involved in the inhibition of egg laying, NLP-
7 and FLP-11 peptides do not strictly depend on Gi/o G-protein coupled receptor (GPCR) 
signaling. Instead, inhibition involves redundant functions of Gi/o and the gustatory 
receptor-like protein EGL-47. Our studies support a model where neuropeptide signaling 
controls the temporal organization of opposing behavioral states by altering synaptic 
vesicle abundance in motor output neurons. 
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Results 
 
Altering uv1 activity affects the timing of egg-laying events 
To begin to address the role of the uv1 cells in neuromodulatory control of egg-
laying, we first asked whether manipulations that alter uv1 activity affect the retention of 
eggs in utero, an indirect measure of egg-laying activity. Wild type adults typically retain 
about 15 eggs in utero under normal laboratory conditions. We used cell-specific 
expression of a histamine-gated chloride channel (HisCl1) to selectively hyperpolarize the 
uv1 cells (Pokala et al., 2014). The ocr-2 promoter region and 3’ UTR regions provide for 
selective expression in the uv1 cells and a few additional head and tail neurons (Jose et 
al., 2007). Using these regulatory regions to drive HisCl1 expression, we silenced uv1 
cells with exposure to exogenous histamine (6 hrs) and then measured the number of 
eggs retained in the uterus (Figure 1B). Transgenic animals expressing HisCl1 without 
exposure to exogenous histamine retain a similar number of eggs to wild type. Histamine-
mediated hyperpolarization of the uv1 cells causes a significant reduction in the number 
of eggs in utero (31%, p < 0.0001), consistent with an increased rate of egg-laying. To 
investigate this further, we next asked whether hyperpolarization of the uv1 cells altered 
the temporal organization of egg-laying events by monitoring egg-laying in freely moving 
animals (Figure 1C, D). Under favorable growth conditions, bouts of egg-laying (clusters) 
are separated by prolonged inactive phases (15-60 mins) in which eggs are retained in 
the uterus. We found that uv1 hyperpolarization causes a significant shift towards shorter 
inactive phases (Figure 1D). 
We next sought to determine whether uv1 activation is sufficient to inhibit egg-laying. 
To address this question, we expressed channelrhodopsin (ChR2) in uv1 cells using the 
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regulatory regions of ocr-2 as above. Light stimulation immediately following the initial 
egg-laying event of an active phase (see Methods) significantly delays subsequent egg-
laying events, and also significantly reduces the total number of egg-laying events within 
an active phase (Figure 2)(Movie S1). For example, under control conditions a majority 
(~80%) of animals show a delay between the first and second egg-laying events within 
an active phase of <20 s (light stimulation, -ATR) (Figure 2B). This proportion is reduced 
dramatically (to around 10%) when uv1 cells are activated (light stimulation, +ATR). In 
addition, a significant fraction of uv1 activated animals (~33%, compared with 11% of 
controls) halt egg-laying for >5 mins following light stimulation, likely indicating termination 
of the active phase (Figure 2B). Of the animals that progress to a second egg-laying 
event, the average time interval between the first and second egg-laying events increases 
from roughly 12 s under control conditions to nearly 38 s with uv1 depolarization. 
Approximately 30% of the animals tested lay 5 or more eggs within an active phase under 
control conditions, but active phases with >5 events are not observed with uv1 
depolarization (Figure 2C). Moreover, about 60% of uv1-activated animals lay ≤2 eggs 
after light stimulation compared to just 22% of animals under control conditions. Taken 
together, our findings provide evidence that uv1-mediated inhibition of egg-laying 
promotes periods of quiescence in the egg-laying program and plays a key role in setting 
their duration. 
 
NLP-7 and FLP-11 neuropeptides are expressed in the uv1 cells and synergistically 
inhibit egg-laying behavior 
	 33	
The dense core vesicle marker IDA-1 is expressed in the uv1 cells, and we noted 
that an IDA-1::GFP translational fusion produces punctate fluorescence in the uv1 cells, 
consistent with prior reports documenting the presence of secretory vesicles in uv1 cells 
(Schinkmann and Li, 1992; Zahn et al., 2001; Zahn et al., 2004) (Figure S1A). These 
findings suggest that neuromodulatory signals are likely to be important for uv1 regulation 
of egg-laying. We therefore investigated the expression of several neuropeptide 
precursors–potential dense core vesicle cargoes–in the uv1 cells. We used a reporter 
construct in which coding sequence for the fluorescent protein mCherry preceded by the 
SL2 splice leader was added to the native genomic sequence encoding selected 
neuropeptide precursors. This bicistronic vector drives expression of the precursor and 
the mCherry reporter under the control of native regulatory sequences. Amongst the 
candidates tested, the NLP-7 precursor was of particular interest, producing mCherry 
fluorescence in cells neighboring the vulva (Figure S1B). We also observed mCherry 
fluorescence in head and tail neurons, consistent with a prior report (Nathoo et al., 2001). 
The mCherry fluorescence near the vulva clearly labels the uv1 cells and the VC4 and 
VC5 motor neurons, and overlaps with that of IDA-1::GFP (Figure 3B and S1C). The nlp-
7 gene encodes four mature peptides that belong to the SFamide family (Figure S1D), 
but functions for these peptides have only recently begun to be elucidated (Mills et al., 
2012; Park et al., 2009; Park et al., 2010). We also confirmed expression of a second 
neuropeptide precursor, flp-11, in the uv1 cells using a Pflp-11::GFP transcriptional 
reporter. Consistent with previous reports (Kim and Li, 2004; Turek et al., 2016), we 
observed flp-11::GFP fluorescence in head and tail neurons, and also prominently in the 
uv1 cells and VC4 and VC5 motor neurons (Figures S2A and 3B). While flp-11::GFP 
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expression is evident in at least one uv1 cell of all adults tested, and remains detectable 
throughout adulthood, the number of uv1s labeled is somewhat variable across 
individuals. The flp-11 neuropeptide precursor is predicted to give rise to four mature 
peptides of the FMRFamide class (Figure S2B) and flp-11 expression in RIS neurons 
located in the head has been previously implicated in the control of sleep (Turek et al., 
2016). Our demonstration of nlp-7 and flp-11 expression in the egg-laying circuit raises 
the interesting possibility that local release of these peptides may regulate circuit 
performance and egg-laying behavior. 
To explore the above possibility, we first investigated egg-laying behavior in nlp-7 
and flp-11 single deletion mutants. nlp-7(lf) and flp-11(lf) animals were not significantly 
different from the wild type with respect to the number of eggs retained in the uterus 
(Figure 3D). Similarly, single deletion of nlp-7 or flp-11 does not significantly advance the 
developmental stage at which embryos are laid (1-8 cell stage: wild type 10%, nlp-7(lf) 
10%, flp-11(lf) 6%, n>80 eggs for each genotype), suggesting that loss of either single 
neuropeptide precursor does not appreciably affect the rate of egg-laying. 
Neuropeptides often work in parallel pathways to mediate specific behavioral 
outcomes. To test whether NLP-7 and FLP-11 may be acting cooperatively to regulate 
egg-laying, we investigated egg-laying behavior in nlp-7(lf);flp-11(lf) double mutants. 
Strikingly, we found that the double mutants retain significantly fewer eggs in utero than 
either wild type or the respective single mutants (Figure 3C, D). In addition, double 
mutants lay a significantly higher percentage of eggs in the early cell stage (1-8 cell stage) 
than wild type (wild type: 10%; nlp-7(lf);flp-11(lf): 58%, n>100 eggs for each 
genotype)(Figures 5D and S3). Transgenic expression of wild type nlp-7 or flp-11 in nlp-
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7(lf);flp-11(lf) double mutants under control of their respective native promoters reverses 
these effects (Figure 3D). Thus, our findings suggest that either class of peptides, if 
present at sufficient levels, is capable of slowing the rate of egg-laying. Indeed, transgenic 
expression of nlp-7 increases the retention of eggs in utero beyond wild type levels, 
suggesting that a chronic increase in circulating levels of NLP-7 peptides may be 
sufficient to produce prolonged inhibition of the egg-laying circuit and deficits in egg-
laying. 
To address whether specific peptide expression in in the uv1 cells is sufficient to 
rescue constitutive egg-laying in nlp-7(lf);flp-11(lf) mutants, we expressed either nlp-7 or 
flp-11 under the control of ocr-2 regulatory sequence. uv1-specific expression of either 
peptide precursor completely reverses hyperactive egg-laying, supporting the idea that 
the uv1 cells are an important endogenous source of these peptides for regulation of egg-
laying (Figure S3). We therefore next tested whether uv1-mediated inhibition of egg-
laying is dependent on nlp-7 and flp-11 neuropeptides by measuring egg-laying 
responses to uv1 photostimulation in nlp-7(lf);flp-11(lf) double mutants (Figure 3E, 
F)(Movie S2). As described in Figure 2, uv1 stimulation in control animals increases the 
interval between egg-laying events and reduces the number of events during an active 
phase. For depolarization of uv1 cells in nlp-7(lf);flp-11(lf) double mutants, the interval 
between consecutive egg-laying events is significantly decreased compared to uv1 
stimulation in controls. Moreover, 90% of nlp-7(lf);flp-11(lf) double mutants perform ≥3 
egg-laying events following light stimulation compared with 40% of controls that perform 
≥3 events (Figure 3E, F). These results support the idea that secretion of NLP-7 and FLP-
11 peptides in response to stimulation of the uv1 cells is sufficient to inhibit egg-laying. 
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However, we note that the effects of uv1 stimulation are not completely reversed in nlp-
7;flp-11 double mutants, consistent with the possibility that other modulatory signals may 
also contribute to uv1 regulation of egg-laying. 
To determine which aspects of the egg-laying behavioral program may be subject to 
modulation by NLP-7 and FLP-11 peptides, we monitored the timing of egg-laying events 
in freely moving animals. In particular, we quantified the time intervals between 
consecutive active phases of egg-laying (intercluster intervals) as well as intervals 
between individual egg-laying events within an active phase (intracluster intervals). The 
duration of intercluster intervals in nlp-7(lf);flp-11(lf) double mutants is strikingly reduced 
compared with wild type or either single mutant (Figure 4A, B). In contrast, the duration 
of intracluster intervals is largely unaffected. Together, these results support a model 
where coordinated actions of NLP-7 and FLP-11 slow the rate of egg-laying by prolonging 
the length of the inactive phase (i.e. delaying transitions to the active phase). 
 
Local release of NLP-7 peptides from uv1 cells produces sustained inhibition of 
egg-laying 
Our findings in the above rescue experiments prompted us to investigate whether 
increasing NLP-7 peptide levels may be sufficient to modify egg-laying behavior and, over 
time, lead to an egg-laying defective phenotype. To explore this possibility further, we 
expressed the nlp-7 genomic sequence (including ~3.5 kb promoter region and 3’ UTR) 
at high levels in otherwise wild type animals. We found that egg-laying behavior is 
severely disrupted in animals stably expressing the nlp-7 transgene (NLP-7 OE; ufIs118) 
(Figure 5A, B). In particular, these animals retain significantly more eggs in utero than the 
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wild type (Figure 5B), and lay a significantly higher percentage of eggs in later stages of 
development (~95% in comma to 3-fold stage compared with 0 in the wild type)(Figure 
5D, E). In contrast, overexpression of flp-11 does not cause significant retention of eggs, 
but does rescue constitutive egg-laying in nlp-7;flp-11 double mutants as noted above 
(Figure 3). The retention of eggs in utero with nlp-7 overexpression provides evidence 
that chronic increases in NLP-7 peptide levels are sufficient to suppress egg-laying.  
In order to investigate the time course over which NLP-7 may act in the control of 
egg-laying we next asked whether acute nlp-7 expression is also sufficient to alter egg-
laying. To address this question, we expressed nlp-7 under the control of a heat-inducible 
promoter. At a constant temperature of 20°C, animals carrying this transgene do not show 
any obvious egg-laying defects (Figure 5C(i)) compared to non-transgenic controls. In 
contrast, exposing transgenic animals to a brief heat shock stimulus (33°C for 30 mins) 
produces a striking decrease in the rate of egg-laying. This decrease is evident within 2 
hours following heat shock and lasted for a period of approximately four hours (Figure 
5C(ii)). Further, these decreases are reversible, with animals increasing their egg-laying 
rates approximately 4 hrs following heat shock, such that total egg-laying approaches 
control levels by 6 hrs after heat shock (Figure 5C(ii)). These findings demonstrate that 
an acute rise in NLP-7 peptide levels is sufficient to block egg-laying in adult animals, and 
the time course of these effects suggests that the actions of NLP-7 are transient, 
consistent with the predicted modulatory effects of a neuropeptide. 
We next pursued cell type-specific overexpression of nlp-7 to decipher where 
peptide expression may be required for modulation of egg-laying. Our prior expression 
studies revealed that nlp-7 is expressed in cells proximal to the vulva (uv1 and VC4/5) as 
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well as in neurons near the head and tail that are distal to the core egg-laying circuit. An 
analysis of the nlp-7 promoter region revealed a 2.5 kb fragment that drove predominant 
expression in the head and tail neurons, but provided more limited expression in the egg-
laying circuit (fluorescence in egg-laying cells was visible in roughly 60% of animals). 
Using this 2.5 kb promoter to drive expression, we investigated egg-laying in the group of 
animals where we were able to confirm nlp-7 expression was restricted to head and tail 
neurons. Selective expression in head and tail neurons does not produce an appreciable 
difference in the developmental stage of embryos at the time of egg-laying (Figure 5F), 
indicating that expression in these neurons alone is not sufficient for modulation of egg-
laying activity. We also analyzed egg-laying in the group of animals for which we observed 
nlp-7 expression in both head and tail neurons and the egg-laying cells (uv1 as well as 
more variable expression in the VC4 and VC5 neurons) using the shorter 2.5 kb nlp-7 
promoter fragment. We noted a significant increase in the fraction of eggs laid at later 
developmental stages in these animals (Figure 5G). To decipher which cells may be most 
critical, we used cell-specific promoters to drive overexpression of nlp-7. Surprisingly, 
despite the spatial proximity of the VC4 and VC5 neurons to the HSNs and vulval 
muscles, specific expression of nlp-7 in the VC neurons (lin-11 promoter fragment) does 
not alter egg-laying (Figure 5H). In contrast, specific expression in the uv1 cells (using 
ocr-2 promoter and 3’ UTR) produces a striking shift in the developmental stage of eggs 
at the time of egg-laying (Figure 5I), similar to that observed using the 3.5 kb native nlp-
7 promoter. Together, our results support the idea that local NLP-7 release from uv1 cells 
is required for modulation of egg-laying activity. Further, the inability to elicit changes in 
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egg-laying activity with expression in neighboring VC neurons may point toward a 
specialized role for the uv1 cells within the circuit. 
 
NLP-7 and FLP-11 reduce the activity of the egg-laying circuit 
Synaptic release from the HSN neurons onto vulval muscles is a key factor in the 
control of egg-laying activity. Therefore, to begin to address the question of how the 
behavioral effects of peptide modulation may be encoded within the egg-laying circuit, we 
next investigated whether neuropeptide signaling altered responsiveness in this core egg-
laying pathway. Prior work showed that photostimulation of transgenic animals that 
express ChR2 in the HSNs is sufficient to elicit an active period of egg-laying (Emtage et 
al., 2012) (Figure 6A). We therefore asked whether neuropeptide signaling affected bouts 
of egg-laying elicited by HSN photostimulation. We quantified egg-laying events in 
response to a 60 s period of light stimulation, measuring the time interval between the 
onset of light exposure and the initial egg-laying event as described previously (Emtage 
et al., 2012) (Movie S3). As expected, control animals expressing ChR2 respond in a 
dose-dependent manner to blue light stimulation–the time interval to the initial egg-laying 
event decreased with increasing light intensities (Figure 6B). Using a light intensity that 
produced an intermediate response in controls (20 W/m2), we found that nlp-7(lf);flp-11(lf) 
double mutants are hypersensitive to light stimulation–there is a significant increase in 
the fraction of animals that respond to light stimulation over time compared with control 
animals or either single mutant (Figure 6C). In contrast, nlp-7 overexpression completely 
blocks egg-laying responses to HSN photostimulation. Whereas almost 60% of wild type 
animals respond within 20 secs of blue light exposure, NLP-7 OE animals show no 
	 40	
response within the 60 s period of light exposure (Figure 6D). Likewise, higher light 
intensities (up to 200 W/m2) do not elicit egg-laying responses in NLP-7 OE animals (none 
of the animals tested respond within 60 s, n=30). Thus, altering peptide levels can have 
profound effects in this core HSN-muscle pathway, suggesting that NLP-7 and FLP-11 
peptides likely inhibit egg-laying behavior either by acting to inhibit neurotransmitter 
release from the HSN neurons or by reducing responsiveness of egg-laying muscles. 
 
Elevating serotonin release or supplying exogenous serotonin reverses egg-laying 
defects caused by increased NLP-7 
Based on our above optogenetic analysis, we used multiple approaches to explore 
mechanisms by which NLP-7 and FLP-11 peptides regulate HSN-muscle signaling and 
egg-laying. The HSNs are primarily serotonergic and we therefore first tested whether 
pharmacological approaches that alter serotonin levels would normalize egg-laying in 
NLP-7 OE animals. Prior work demonstrated that the egg-laying defects produced by 
serotonin deficiency are reversed by supplying exogenous serotonin (Desai and Horvitz, 
1989; Trent et al., 1983). We found that serotonin exposure stimulates egg-laying similarly 
in both wild type animals and neuropeptide-deficient single mutants. Serotonin exposure 
elicits fewer egg-laying events in nlp-7;flp-11 double mutants, likely due to the fact that 
these animals display constitutive egg-laying and retain fewer eggs in utero (Figure 3D). 
Strikingly, serotonin exposure also promotes egg-laying in NLP-7 OE animals, suggesting 
that egg-laying defects in these animals might arise through a deficiency in serotonin 
levels (Figure 7A). Consistent with this interpretation, we found that the serotonin 
reuptake inhibitor fluoxetine elicits far less egg-laying activity in NLP-7 OE animals 
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compared with wild type (Figure 7B). Fluoxetine exposure also elicits a reduced number 
of egg-laying events in nlp-7;flp-11 double mutants compared with wild type, again likely 
because these animals retain fewer eggs in utero. 
We next pursued several genetic approaches to ask whether HSN activity and 
serotonin release are regulated by neuropeptide signaling. We used available loss-of-
function mutations in egl-47 and goa-1, two genes that act primarily in the HSNs to inhibit 
egg-laying, to elevate HSN signaling (Mendel et al., 1995; Moresco and Koelle, 2004; 
Segalat et al., 1995; Shyn et al., 2003) (Figure 7C). egl-47 encodes a seven 
transmembrane protein bearing homology to Drosophila gustatory receptors (Liu et al., 
2010) while goa-1 encodes Gao, the only inhibitory G-protein subunit expressed in the 
HSNs. Mutation of egl-47 partially reverses NLP-7 inhibition of egg-laying (Figure 7D). 
Though loss of goa-1 produces constitutive egg-laying in otherwise wild type animals, we 
did not observe appreciable differences in egg-laying between control NLP-7 OE animals 
and NLP-7 OE animals carrying a goa-1(lf) mutation. Combined mutation of egl-47 and 
goa-1 however completely reverses the effects of nlp-7 overexpression, eliciting a 
constitutive egg-laying phenotype comparable to that of goa-1(lf) single mutants (Figure 
7D). We next examined whether combined mutation of egl-47 and goa-1 in NLP-7OE 
animals restored responsiveness to HSN photostimulation. Egg-laying responses elicited 
by ChR2 activation of the HSNs approach wild type levels in these animals (Figure 7E), 
providing additional evidence that NLP-7 inhibition of egg-laying is reversible with 
increases in HSN signaling. Finally, we asked whether increasing muscle synaptic 
activation could suppress NLP-7 mediated inhibition of egg laying. Cholinergic 
transmission at synapses between VC neurons and egg-laying muscles operates in 
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parallel with HSN signaling onto muscles to control their excitability. Vulval muscles 
express acetylcholine receptors that are responsive to the nematode-specific cholinergic 
agonist levamisole, and exposure to exogenous levamisole stimulates egg-laying (Kim et 
al., 2001). We increased cholinergic synaptic activation of muscles by expressing a gain-
of-function muscle acetylcholine receptor (L-AChR(gf)) (Bhattacharya et al., 2014). 
Transgenic expression of L-AChR(gf) in otherwise wild type animals increases egg-laying 
activity, producing a constitutive phenotype (Figure 7F). In contrast, expression of L-
AChR(gf) in NLP-7 OE animals does not appreciably change the rate of egg-laying, 
indicating that elevated cholinergic synaptic activation of muscles cannot reverse the 
inhibition produced by increased levels of NLP-7 signaling. Interestingly, NLP-7 OE 
animals expressing the L-AChR(gf) transgene show enhanced egg-laying with a supply 
of exogenous serotonin (–5-HT: 0.4±0.3 eggs/hour; +5-HT: 12.8±1.9 eggs/hour, 
p<0.0001, t-test), consistent with the notion that the production or release of serotonin 
may be impaired in NLP-7 OE animals. 
As noted above, FLP-11 expression is sufficient for rescue of constitutive egg-laying 
in nlp-7;flp-11 double mutants, but overexpression does not elicit sustained inhibitory 
effects. Therefore, we were unable to pursue a similar genetic analysis of FLP-11 
signaling. This could be due to a functional property of the FLP-11 signaling pathway or 
may indicate that our strategies for increasing neuropeptide expression were less 
effective for FLP-11. Nonetheless, our findings for NLP-7 argue that these peptides act 
primarily to control levels of serotonin secretion from the HSNs. Prior work showed that 
HSNs exhibit spontaneous Ca2+ oscillations even in the absence of synaptic inputs 
(Zhang et al., 2008). Therefore, our findings suggest a model where local neuropeptide 
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release from the uv1 cells may control circuit activity, in part by shaping the timing of 
vesicular serotonin release from the HSNs. 
 
NLP-7 regulates synaptic vesicle abundance in the HSN neurons 
To gain additional support for peptide regulation of HSN transmission, we next 
examined the distribution of synaptic vesicles at HSN synapses onto vulval muscles. 
Numerous previous studies have employed the synaptic vesicle marker synaptobrevin 
(SNB-1) to investigate alterations in the distribution of synaptic vesicles in the HSNs 
(Nonet, 1999; Shen and Bargmann, 2003; Shen et al., 2004; Tanis et al., 2008; Tanis et 
al., 2009). Therefore for our analysis, we used a transgenic strain in which GFP-tagged 
synaptobrevin (SNB-1::GFP) is stably coexpressed specifically in the HSN neurons with 
the fluorescent reporter DsRed2 (Tanis et al., 2008). 
In wild type animals, the HSN process forms two to four synaptic varicosities within 
10µm of the vulval opening where synaptic contacts with the Vm2 vulval muscles are 
located (Tanis et al., 2009). We did not observe significant changes in the morphological 
features of the HSN neurons in either of the neuropeptide single mutants or in nlp-7;flp-
11 double mutants. Likewise, the total synaptic volume (Figure S5A) and the number of 
synaptic varicosities (Figure S5B) within the HSN process are unaffected by single or 
combined deletion of the flp-11 and nlp-7 neuropeptide precursors, suggesting that the 
sizes of the synaptic region are not altered. However, we noted a significant increase in 
the intensity of SNB-1::GFP fluorescence in both nlp-7(lf) single mutants and nlp-7(lf);flp-
11(lf) double mutants (Figure 8B), suggesting that synaptic vesicle abundance in the HSN 
neurons is increased in these animals. In principle, the increase in vesicle abundance 
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could affect either egg-laying activity during the active phase or the length of the quiescent 
period. Despite increased SNB-1::GFP, we did not observe a significant change in the 
number of egg-laying events/active phase for either nlp-7(lf) single mutants and nlp-
7(lf);flp-11(lf) double mutants (wild type: 3.8±0.3; nlp-7(lf): 4.1±0.3; nlp-7(lf);flp-11(lf): 
3.2±0.2), supporting the idea these peptides act primarily to increase the length of the 
quiescent period. Deletion of flp-11 did not produce an appreciable difference in SNB-
1::GFP intensity, suggesting that HSN regulation may be primarily mediated through NLP-
7 peptides, while FLP-11 peptides may modulate egg-laying activity via another 
mechanism. Conversely, we noted a significant decrease in SNB-1::GFP fluorescent 
intensity in NLP-7 OE animals (Figure 8A, B), though the total volume of the synaptic 
region remained unchanged (Figure S5A). Finally, DsRed2 fluorescent intensity 
(expressed under the same promoter as SNB-1::GFP) in either the synaptic region or the 
HSN cell body is not significantly affected by combined peptide deletion or by NLP-7 
overexpression (Figures 8C and S5E), providing evidence that the changes in SNB-
1::GFP fluorescence we observe do not arise via transcriptional regulation of the reporter. 
Similarly, neither localization or expression of the active zone marker GFP::SYD-2 were 
appreciably altered by peptide deletion or overexpression (Chia et al., 2013) (Figure S6), 
providing additional evidence that synapse organization is not affected by altering 
neuropeptide signaling. In contrast, SNB-1::GFP fluorescent intensity in the HSN cell 
bodies is significantly reduced by NLP-7 overexpression, similar to the synaptic region 
(Figure S5C, D). Together, our analysis supports a model where neuropeptide secretion 
from the uv1 cells modulates egg-laying activity, at least in part by limiting the abundance 
of serotonergic synaptic vesicles at HSN synapses. As reduced synaptic vesicle 
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trafficking to synapses might be expected to lead to an accumulation of synaptic vesicles 
in the cell body, we propose that this regulation occurs via an alternate mechanism, 
perhaps through direct or indirect regulation of synaptic vesicle biogenesis. 
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Discussion 
Neuromodulatory signaling enables hardwired circuits to maintain flexibility for 
generating alternate activity patterns and behaviors in response to either changes in 
environmental conditions or internal state of the organism. Gaining a mechanistic 
understanding of these processes in vivo however has remained a challenge. Our studies 
here demonstrate that neuropeptide modulation of neurotransmitter release controls the 
temporal pattern of C. elegans egg-laying activity. While prior work has provided 
examples of neuromodulatory control of egg-laying in response to external environmental 
factors (Fenk and de Bono, 2015; Ringstad and Horvitz, 2008; Waggoner et al., 2000; 
Zhang et al., 2008), our work demonstrates that neuromodulatory signaling is central for 
establishing the timing of egg-laying activity even under relatively constant favorable 
external conditions.  
Prior work suggested that the neurosecretory uv1 cells may terminate egg-laying, 
perhaps by sensing the passage of eggs through the vulva (Collins et al. 2016; Jose et 
al., 2007). Our work supports this model and extends it in several important aspects. First, 
we show that activating or inhibiting the uv1 cells produces predictable changes in the 
periodicity of egg-laying. Second, we identify two neuropeptide precursors, NLP-7 and 
FLP-11, that are expressed in uv1 cells and work cooperatively to set the duration of 
inactive phases during egg-laying. For both neuropeptide precursors, specific expression 
in the uv1 cells is sufficient to slow the rate of egg-laying, suggesting that local secretion 
solely from uv1 cells can account for their effects in vivo. Third, we show that nlp-7 
overexpression produces robust and sustained inhibition of egg-laying, and provide 
evidence that this occurs through negative regulation of serotonin signaling from the HSN 
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neurons. Finally, genetic ablation or overexpression of nlp-7 produce opposing effects on 
synaptic vesicle abundance in the HSN neurons. Genetic alteration of flp-11 levels does 
not reproduce these effects, suggesting flp-11 may act via another mechanism or target 
another cell type in the circuit. Together, our findings support a model where peptides 
derived from NLP-7 and FLP-11 are coordinately secreted from uv1 cells to modify egg-
laying circuit activity and shape the temporal organization of egg-laying behavior. We 
propose that the secretion of NLP-7 and FLP-11 peptides from uv1 cells promote egg-
laying quiescent periods by reducing serotonin release from the HSN neurons. This is 
achieved, at least in part, by regulating the abundance of serotonergic synaptic vesicles 
in the HSN neurons (Figure S7). Prior work showed that neuropeptides encoded by the 
flp-1 gene promote the onset of egg-laying active phases (Waggoner et al., 2000). It is 
therefore appealing to speculate that the NLP-7/FLP-11 and FLP-1 neurotransmitter 
systems act antagonistically to shape egg-laying behavior. One intriguing possibility is 
that FLP-1 peptides primarily act in response to sensory stimuli (such as food availability) 
to alter an intrinsic rhythm established through the actions of NLP-7/FLP-11 signaling. 
Our studies indicate that local neuropeptide signaling plays a central role in 
establishing behavioral rhythmicity during egg-laying. In particular, we find that cell-
specific expression of flp-11 or nlp-7 is sufficient to rescue egg-laying defects or, in the 
case of nlp-7, produce sustained inhibition of egg-laying. Interestingly, cell-specific 
expression of nlp-7 in VC motor neurons did not reproduce these effects, even though 
these neurons are located in close proximity to both HSN neurons and egg-laying 
muscles. This finding points toward the idea that the uv1 cells perform specialized 
neurosecretory functions in halting egg-laying. For example, uv1 cells may be specialized 
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for properly coordinating the timing of neuropeptide release with egg-laying activity or 
perhaps possess expanded capacity for neuropeptide release compared with neighboring 
neurons. Unfortunately, it has proven difficult to assess uv1 function directly. These cells 
are an essential structural component of the egg-laying anatomy, limiting the value of 
ablation studies or mutants deficient in uv1 development for addressing questions about 
function (Jose et al., 2007; Huang and Hanna-Rose, 2006). Prior studies exploited a 
dominant mutation in the TRPV channel ocr-2 to strongly implicate uv1 cells in the 
regulation of egg-laying, but mechanistic interpretation of these studies is complicated by 
our limited understanding of the effects of the mutation on channel functional properties 
(Jose et al., 2007). We used expression of a histamine gated chloride channel to inhibit 
uv1 activity. Prolonged inhibition of the uv1 cells in adult animals significantly reduces the 
length of the inactive phase of egg-laying. A recent study found that calcium transients 
occur in uv1 cells immediately following egg-laying events during an active phase (Collins 
et al., 2016), suggesting that repetitive stimulation of uv1 cells may be required for 
inhibition of egg-laying. We speculate that each egg-laying event may trigger release from 
the uv1 cells, ultimately leading to local increases in peptide levels sufficient to terminate 
the active phase and delay re-entry into the subsequent active phase. This model is 
supported by several observations: (1) ChR2 depolarization of uv1 cells delays 
subsequent egg-laying events in an active phase and even terminates the active phase 
in a subset of animals. (2) The effects of uv1 stimulation are almost completely eliminated 
in double mutants lacking NLP-7 and FLP-11 peptides. (3) uv1-specific rescue or 
overexpression of flp-11 and nlp-7 demonstrate that high levels of either peptide are 
sufficient to inhibit egg-laying. Moreover, induced expression of NLP-7 peptides in adults 
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slows egg-laying within two hours and these effects begin to reverse by four hours. uv1 
cells may share interesting parallels with oxytocin (OT) neurosecretory cells of the 
hypothalamus that are involved in the control of lactation. Secretion of OT (and 
subsequently milk ejection) is not temporally locked to the initiation of suckling but instead 
must surpass a certain threshold during suckling for a burst of OT release and milk 
ejection to occur (Armstrong, 2007; Stern and Armstrong, 1996). Similarly, we speculate 
that uv1 cells require a buildup of egg-laying events during an active phase to achieve 
sufficient levels of NLP-7 and FLP-11 peptides to terminate an active phase. These 
neuropeptides may also work in concert with other modes of uv1 signaling. For example, 
genetic disruption of tyraminergic signaling produces defects in egg-laying and prior work 
showed that tyramine was present in the uv1 cells (Alkema et al., 2005). As is the case 
for nlp-7;flp-11 double mutants, the effects of tyramine deficiency are incomplete, 
suggesting that these signals may cooperate to alter circuit performance in complex ways. 
While our work supports the idea that neuropeptide secretion from uv1 cells is key 
for proper temporal organization of egg-laying, the nature of the sensor that triggers 
peptide secretion remains an open question. All of our studies are performed under 
constant favorable external conditions. Therefore, peptide secretion from uv1 cells is 
likely triggered by sensing a change in the internal state of the organism, perhaps by 
sensing egg-laying status. Based on their anatomical position and expression of 
mechanosensory TRPV channels, the uv1 cells have been proposed to sense the 
mechanical load of the uterus (Jose et al., 2007). Consistent with this idea, recent 
evidence indicates that uv1 cells are mechanically deformed with the passage of eggs 
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through the vulva (Collins et al., 2016). Thus, mechanical deformation of the uv1 cells 
may directly trigger rises in intracellular Ca2+ and peptide secretion. 
Our genetic analysis of nlp-7 overexpression provides evidence that NLP-7 peptides 
act primarily at the level of the HSNs to inhibit egg-laying. We found that combined 
mutation of egl-47 and goa-1 completely suppress the effects of nlp-7 overexpression. 
Prior work demonstrated that each of these genes mediate their effects on egg-laying by 
acting primarily in the HSN neurons (Moresco and Koelle, 2004), although goa-1 
expression in vulval muscles or uv1 cells may also contribute (Jose et al., 2007; Mendel 
et al., 1995). Nonetheless, it is difficult to conclusively demonstrate that the HSN neurons 
are the sole site of action for these peptides in the egg-laying circuit because high-affinity 
receptors for NLP-7 peptides have not yet been identified, and the cellular expression of 
several putative FLP-11 receptors remains uncharacterized. egl-6 encodes the sole 
GPCR that has been previously demonstrated to show expression in the HSN neurons, 
but NLP-7 peptides do not activate EGL-6 in vitro (Ringstad and Horvitz, 2008). Though 
a precise mechanism for EGL-47 action remains unclear, our finding that mutation of egl-
47 partially restores egg-laying in NLP-7 OE animals raises the intriguing possibility that 
EGL-47 may act directly as a receptor for NLP-7 peptides. egl-47 encodes a seven-
transmembrane protein related to Drosophila gustatory receptors (Bargmann, 2006; Liu 
et al., 2010). While gain-of-function egl-47 mutation inhibits egg-laying, our studies here 
are the first to demonstrate a phenotype associated with egl-47 loss of function. Initial 
studies suggested that egl-47 may be an orphan GPCR (Moresco and Koelle, 2004), 
while more recent studies suggest that EGL-47 inhibition of egg-laying may occur through 
activation of an associated chloride channel (Tanis et al., 2009). In addition, our findings 
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reveal that the egg-laying defects of NLP-7 overexpressing animals are completely 
suppressed only by combined mutation of egl-47 and goa-1. This observation points 
towards the interesting possibility that multiple receptors might act downstream of NLP-7 
signaling – perhaps EGL-47 in combination with GOA-1 (Gi/o)-coupled GPCR(s). Further 
characterization of EGL-47 and other potential NLP-7 receptors is an important subject 
for future studies. Several potential FLP-11 receptors have been identified to date 
(Frooninckx et al., 2012; Mertens et al., 2004; Mertens et al., 2006; Turek et al., 2016), 
but expression of these receptors in the egg-laying circuit has not yet been demonstrated. 
In our studies, FLP-11 expression in the uv1 cells was sufficient for rescue of constitutive 
egg-laying in nlp-7;flp-11 double mutants, but overexpression did not produce obvious 
defects, preventing pursuit of a genetic suppressor approach to identify the GPCR(s) 
involved. 
Our studies also address the question of how peptides secreted from the uv1 cells 
modulate egg-laying. Our analysis of SNB-1::GFP fluorescence in the HSN neurons 
offers support for the idea that NLP-7 peptides act, at least partially, by modulating HSN 
transmission onto egg-laying muscles. We observed an increase in SNB-1::GFP 
fluorescence at HSN synapses in nlp-7(lf);flp-11(lf) mutants, and a strong decrease with 
nlp-7 overexpression. Because the total synaptic volume and number of varicosities are 
unaffected, we propose that these fluorescence changes reflect altered synaptic vesicle 
density. We therefore interpret our findings to indicate that peptidergic signaling alters 
synaptic vesicle abundance in the HSN neurons. This interpretation is supported by our 
HSN photostimulation studies where we found that nlp-7(lf);flp-11(lf) double mutants 
exhibit enhanced egg-laying responsiveness to HSN depolarization, while NLP-7 OE 
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animals are resistant. Prior work has identified mechanisms for intrinsic regulation of HSN 
activity (Branicky et al., 2014; Emtage et al., 2012; Tanis et al., 2009; Zhang et al., 2008). 
In particular, the potassium channel IRK-1 is important for inhibition of HSN activity by the 
EGL-6 GPCR. Although acting independently of EGL-6, NLP-7 and FLP-11 peptides 
might similarly exert their effects by inhibiting HSN activity. Our analysis of SNB-1::GFP 
fluorescence is not however consistent with the peptides acting solely via this mechanism. 
For example, if NLP-7 peptides inhibited egg-laying simply by decreasing HSN activity, 
we might expect an increase in SNB-1::GFP fluorescence at synapses due to a reduced 
rate of vesicular release. Surprisingly, we observe that NLP-7 mediated inhibition of egg-
laying is associated with a strong decrease in SNB-1::GFP intensity, suggesting other 
processes contribute. One possibility is that chronic peptidergic inhibition of the HSNs 
leads to a compensatory decrease in the production of synaptic vesicles. Alternatively, 
neuropeptide signaling may directly modulate the rate of synaptic vesicle trafficking to 
HSN synapses. This possibility appears unlikely because we do not observe increased 
SNB-1::GFP intensity in the HSN cell bodies of NLP-7 OE animals, as would be expected 
if vesicles were accumulating in the HSN soma. Finally, peptidergic signaling may directly 
alter rates of HSN synaptic vesicle recycling or biogenesis. A previous report 
demonstrated that serotonin expression in the HSNs is altered by G-protein signaling 
(Tanis et al., 2008). Our findings may suggest the presence of a parallel mechanism in 
the HSNs for regulating vesicle production. This would be consistent with our observation 
that SNB-1::GFP intensity is decreased at both HSN synapses and in HSN cell bodies of 
NLP-7 OE animals. Interestingly, we also observed that SNB-1::GFP fluorescent intensity 
is significantly increased at HSN synapses in nlp-7 single mutants, but these animals do 
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not display significant egg-laying defects and likewise are not hypersensitive to HSN 
photostimulation. These results argue that changes in HSN synaptic vesicle abundance 
alone cannot fully account for the actions of FLP-11 and NLP-7 peptides in the egg-laying 
circuit.  
In summary, our results demonstrate a mechanism by which local neuropeptide 
secretion from a group of non-neuronal cells produces relatively long-lived inhibition of 
circuit activity and behavioral quiescence by modulating serotonergic transmission. HSN 
motor neurons exhibit spontaneous activity and serotonin release from the HSNs is 
associated with a transition from the inactive to active phase of egg-laying (Waggoner et 
al., 1998; Zhang et al., 2008). We propose that cycles of neuropeptide release from the 
uv1 cells reversibly inhibit HSN transmission and structure the timing of egg-laying by 
both promoting inactive phases and preventing rapid re-entry into active phases. More 
broadly, our studies elucidate a mechanism by which neuromodulatory systems modify 
circuit activity to specify the timing of transitions between opposing behavioral states. 
Advancing our knowledge of how neuropeptides and other modulators act in the context 
of the circuits in which they are endogenously released will be critical in ongoing efforts 
to understand how alternate behavioral states, for example those underlying mood or 
arousal, are encoded. 
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Materials and Methods 
Strains 
All nematode strains were maintained at 20°C on agar nematode growth media plates 
seeded with E. Coli OP50.  The wild type reference animals for all cases are the N2 Bristol 
strain. The following strains were used or generated in this work: IZ2539: ufIs160[Pocr-
2::HisCl::SL2::GFP:ocr-2 3’ UTR, Plgc-11::mCherry], LX2047: lite-1(ce314);lin-
15(n765ts);vsIs189[Pocr-2::ChR::YFP::ocr-2 3’UTR], IZ2634: nlp-7(tm2984);flp-
11(tm2706);lite-1(ce314);lin-15(n765ts);vsIs189, NY2040: ynIs40[pflp-11::GFP], IZ1130: 
lin-15(n765ts);ufEx378 [pnlp-7::nlp-7::SL2::mCherry], IZ1135: nlp-7(tm2984), IZ2022: flp-
11(tm2706), IZ1589: nlp-7(tm2984);flp-11(tm2706); IZ2263: nlp-7(tm2984);flp-
11(tm2706);ufEx792[Pnlp-7::nlp-7::nlp-7 3’UTR, Plgc-11::GFP], IZ2407: nlp-
7(tm2984);flp-11(tm2706);ufEx876[Pflp-11::flp-11::flp-11 3’ UTR, Plgc-11::GFP], IZ2834: 
nlp-7(tm2984);flp-11(tm2706);ufEx1099 [Pocr-2::nlp-7::ocr-2 3’ UTR, Pocr-
2::mCherry::ocr-2 3’UTR, Plgc-11::GFP], IZ1823: nlp-7(tm2984);flp-
11(tm2706);ufEx582[Pocr-2::flp-11::ocr-2 3’UTR, Pocr-2::mCherry::ocr-2 3’UTR, Plgc-
11::GFP], LX1836: lite-1(ce314);lin-15(n765ts);wzIs30[pegl-6::ChR::YFP], IZ1587: nlp-
7(tm2984); lite-1(ce314);lin-15(n765ts);wzIs30, IZ2008: flp-11(tm2706); lite-1(ce314);lin-
15(n765ts);wzIs30, IZ2007: nlp-7(tm2984);flp-11(tm2706); lite-1(ce314);lin-
15(n765ts);wzIs30, IZ1614: ufIs118;lite-1(ce314);lin-15(n765ts);wzIs30, IZ1236: ufIs118 
[Pnlp-7::nlp-7::nlp-7 3’UTR, Plgc-11::GFP] , IZ2109: ufEx730[Phsp16.2::nlp-7], IZ1594: 
ufEx521[Pocr-2::nlp-7::ocr-2 3’UTR, Plgc-11::mCherry], IZ2006: ufEx681[Plin-11::pes-
10::nlp-7, Plin-11::pes-10::mCherry, Plgc-11::GFP], IZ1692: ufEx548[Pnlp-7(2.5kb)::nlp-
7, Pnlp-7(2.5kb)::mCherry, Plgc-11::GFP], RB850: egl-47(ok677)V , IZ1235: egl-
47(ok677);ufIs118, IZ1324: goa-1(n1134);ufIs118, IZ2096: egl-47(ok677), goa-
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1(n1134);ufIs118, MT2426: goa-1(n1134), IZ2683: egl-47(ok677), goa-1(n1134), IZ2474: 
egl-47(ok677), goa-1(n1134);ufIs118;lite-1(ce314);lin-15(n765ts);wzIs30, IZ236: ufIs6 
[Pmyo-3:: unc-38(V/S), Pmyo-3::unc-29(L/S), Pmyo-3:: lev-1(L/S)], IZ1274: ufIs6;ufIs118, 
LX967: lin-15(n765ts);vsIs103, IZ1881: nlp-7(tm2984); lin-15(n765ts);vsIs103, IZ1880: 
flp-11(tm2706); lin-15(n765ts);vsIs103, IZ1884: nlp-7(tm2984);flp-11(tm2706); lin-
15(n765ts);vsIs103, IZ1812: ufIs118; lin-15(n765ts);vsIs103, BL5752: inIs181(Pida-
1::IDA-1::GFP);inIs182(Pida-1::IDA-1::GFP), IZ2681: inIs181;inIs182;ufEx378, TV38: 
wyIs12 [Punc-86:: GFP::SYD-2, Podr-1::GFP], IZ2818: wyIs12;ufIs118, IZ2819: 
wyIs12;nlp-7(tm2984);flp-11(tm2706). 
 
Molecular Biology and Transgenes 
HisCl: A fragment containing the coding sequence of HisCl SL2 trans-spliced with 
GFP was ligated into pKMC281 (a gift from the Koelle lab) between the ocr-2 promoter 
and the ocr-2 3’ UTR to generate pNB41 (pocr-2::HisCl::SL2::GFP::ocr-2 3’UTR). This 
was injected (100 ng/µl) into N2 animals along with the coinjection marker pBB107 (Plgc-
11::mCherry, 30 ng/µl). The resulting extrachromosomal array was stably inserted by X-
ray integration to generate the transgene ufIs160 and outcrossed four times to wild type. 
nlp-7 expression pattern: pCL17 (Pnlp-7::nlp-7::SL2::mCherry, 50 ng/µl) was 
injected into lin-15(n765ts) animals along with the coinjection marker pL15EK (lin-15(+), 
50 ng/µl). 
nlp-7 and flp-11 rescue: For nlp-7 rescue, a 5104 bp PCR product containing the 
nlp-7 promoter, genomic locus and the 3’UTR (-3448 bp to +1656 bp relative to the 
transcriptional start) was injected at 50 ng/µl into strain IZ1589 along with the coinjection 
	 56	
marker pHP6 (Plgc-11::GFP, 30 ng/µl). For flp-11 rescue, a 3240 bp PCR product 
containing about 2.5 kb of the flp-11 promoter, genomic locus and the 3’UTR (-2518 bp 
to +722 bp relative to the transcriptional start) was injected (100 ng/µl) into strain IZ1589 
along with pHP6 (30 ng/µl). 
NLP-7 overexpression: The NLP-7 OE strain (ufIs118) was generated by 
microinjection and subsequent X-ray integration of a 5104 bp PCR product (injected at 
100 ng/µl) containing the nlp-7 promoter (about 3.5 kb), genomic locus and the 3’UTR (-
3448 bp to +1656 bp relative to the transcriptional start) along with pHP6 (Plgc-11::GFP, 
50 ng/µl) as coinjection marker. The integrated strain was outcrossed five times with wild 
type. 
Heat shock overexpression of nlp-7: pNB35 (Phsp16.2::nlp-7, 100 ng/µl) was 
injected into N2 animals along with pHP6 (Plgc-11::GFP, 30 ng/µl) as coinjection marker.  
Cell specific overexpression of nlp-7 
uv1: The nlp-7 genomic sequence was ligated into pKMC281 (a gift from the Koelle 
lab) between the ocr-2 promoter and the ocr-2 3’ UTR to generate pNB28 (Pocr-2::nlp-
7::ocr-2 3’UTR). A PCR product amplified from this plasmid was injected at 100 ng/µl into 
N2 animals together with pBB107 (30 ng/µl).  
VC: A fragment containing the lin-11 enhancer region fused to the pes-10 basal 
promoter was PCR amplified from pDM4 and ligated into pENTR/D-TOPO vector to 
generate a gateway entry vector. It was recombined with gateway destination vectors 
containing the nlp-7 genomic sequence and mCherry coding sequence to generate 
pNB14 and pNB15. pNB14 (Plin-11::pes-10::nlp-7, 100 ng/µl) was coinjected with pNB15 
(Plin-11::pes-10::mCherry, 80 ng/µl) into N2 animals together with pHP6 (30 ng/µl).  
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Head and tail neurons: A 2537 bp fragment containing the nlp-7 promoter (-2537bp 
relative to transcriptional start) was amplified from genomic DNA and ligated into 
pENTR/D-Topo vector to generate a Gateway entry vector. This was recombined to 
Gateway destination vectors containing the nlp-7 genomic sequence and mCherry coding 
sequence to generate pNB24 (Pnlp-7(2.5kb)::nlp-7) and pNB25 (Pnlp-7(2.5kb)::mCherry) 
respectively. pNB24 (100 ng/µl) and pNB25 (50 ng/µl) were coinjected into N2 animals 
together with pHP6 (30 ng/µl).  
 
Behavioral assays 
Quantification of eggs in uterus. Age-matched adults were obtained by collecting late 
fourth larval stage (L4) animals and culturing at 20°C for 30 hrs (except in Figure 7 where 
synchronized adults 24 hrs after the L4 stage were used). For each strain analyzed, 
animals were individually dissolved in 25% sodium hypochlorite, and their eggs, which 
survived because of their protective eggshells, were quantified. 
Embryo staging assay. To score the developmental stage of newly laid eggs, age-
matched adults (30 hrs after the late L4 stage) were transferred to fresh nematode growth 
medium plates (15 animals per plate), allowed to lay eggs for 30 mins and removed. Eggs 
laid on the plates were examined by a high power dissecting microscope and categorized 
as described in Ringstad and Horvitz, 2008.  
Analysis of temporal pattern of egg-laying. Single one-day old (24-30 hrs after the L4 
stage) adult animals were placed individually on NGM agar plates and videotaped at room 
temperature for 4-5 hours at a rate 0.5 frames/s. Intervals between clusters of egg-laying 
(intercluster intervals) and intervals between individual egg-laying events within a cluster 
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(intracluster intervals) were determined by video analysis and manually scoring the timing 
of egg-laying events.   
HisCl experiments. Histamine plates were made by diluting histamine dihydrochloride 
(Sigma Aldrich) into NGM agar media cooled to 55°C, to a final concentration of 50 mM. 
Plates were stored at 4°C and used within 2 weeks. To quantify the number of eggs in 
utero, age matched adults (24 hrs after the L4 stage) were placed on seeded NGM plates 
with or without histamine. After 6 hrs at room temperature, animals were individually 
bleached and the number of eggs retained in utero were counted. To analyze the timing 
of egg-laying events, one-day old adults were placed on histamine plates. After 1 hr of 
histamine exposure, animals were videotaped for 3-5 hrs while on the same histamine 
plates. The timing of individual egg-laying events was determined by manual video 
analysis. Control animals were treated similarly except that they were placed on plates 
lacking histamine. 
Pharmacological assays. Individual staged adult animals were placed in 50 µl of low salt 
M9 buffer, or M9 containing 7.5 mg/ml serotonin or 0.5 mg/ml fluoxetine. After 1 hour in 
each condition, the number of eggs laid by each animal was quantified. 
Channelrhodopsin experiments. Synchronized young adult animals were transferred to 
retinal plates for roughly 18 hours prior to experiment. To prepare retinal plates, an 
overnight culture of OP50 was mixed with all-trans retinal to a final concentration of 100 
µM and 150 µl of the mix was seeded onto individual NGM agar plates. Plates were stored 
at 4°C under dark conditions and used within one week. Photostimulation experiments 
were conducted using a fluorescent dissecting microscope (Zeiss steREO 
Discovery.V12) equipped with a GFP filter set. Light intensities were measured at the 
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surface of assay plates using a light meter. For all photostimulation experiments, control 
and experimental animals were treated similarly except that controls did not receive 
retinal exposure. 
uv1 stimulation. Single animals were monitored in the presence of retinal. After the first 
egg-laying event of an active phase, the animals were immediately exposed to blue light 
(100 W/m2) for 5 seconds and subsequent egg-laying events were monitored. 
Videotaping was continued for 5-6 mins after the last egg-laying event to ensure the end 
of an active phase. We noted that photostimulation elicited an escape-like response in a 
subset of animals expressing the Pocr-2::ChR2::ocr-2 3’UTR transgene (Movie S1). The 
ocr-2 promoter and 3’ UTR used for ChR2 expression in the uv1 cells also drives 
expression in a small number of sensory neurons near the head (Jose et al., 2007). The 
avoidance behavior we observed likely arises due to activation of these neurons. Notably, 
this avoidance response also occurred nlp-7(lf);flp-11(lf) double mutants where we did 
not observe appreciable inhibition of egg-laying (Movie S2), indicating that the egg-laying 
and locomotory behaviors elicited by light stimulation are separable. NLP-7 and FLP-11 
peptides appear required for inhibition of egg-laying, but are not necessary for the 
avoidance response to light stimulation. 
HSN stimulation. On the day of the experiment, single animals were transferred from 
retinal plates to OP50 plates (without retinal) and assayed immediately for egg-laying 
response to blue light exposure.  
Heat shock overexpression experiments. Groups of 10 age-matched adult animals 
(picked at L4 stage on the day prior to experiments) were transferred to NGM agar plates 
seeded with OP50, wrapped in parafilm and submerged into a water-bath at 33°C for 30 
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mins. After 30 mins, the animals were transferred to 20°C and the number of eggs laid 
were counted every hour.  
 
Microscopy 
Expression patterns. Images were acquired using a Zeiss Axioskop 2 microscope system 
and LSM Pascal 5 imaging software (Zeiss). Images were processed using ImageJ 
software. Worms were mounted on agarose pads and immobilized with 0.3 M sodium 
azide. All images were obtained from staged young adult animals (~24hrs after the L4 
stage).  
HSN imaging and quantification. Images were acquired using an Olympus BX51WI 
spinning disc confocal microscope. Age-matched adults (30 hrs after the L4 stage) were 
immobilized using 0.3 M sodium azide on slides with 2% agarose pads. z-stack images 
of HSN synapses and cell bodies were acquired from all animals. Images were analyzed 
using Volocity6.3 software. Total SNB-1::GFP volume, number of SNB-1::GFP 
varicosities and GFP::SYD-2 clusters in the HSN synaptic regions were determined as 
described in Tanis et al., 2008. Mean SNB-1::GFP and SYD-2::GFP intensities at HSN 
synapses were determined by averaging the mean GFP fluorescence intensities from all 
SNB-1::GFP and SYD-2::GFP varicosities in a single HSN process (within 10 µm of the 
vulval slit) and subtracting the threshold value (1000 units or 1500 units above mean 
background fluorescence for SNB-1::GFP or SYD-2::GFP respectively). DsRed2 
intensities were measured similarly in the same exact regions occupied by SNB-1::GFP.  
 SNB-1::GFP and DsRed2 intensities in HSN cell bodies were determined by 
calculating their mean intensities within each cell body and subtracting the threshold value 
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(1500 units above background). 
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Figure II-1. Reducing the activity of neurosecretory uv1 cells increases egg-laying 
(A) Schematic diagram of the egg-laying circuit. The HSNs make primarily serotonergic 
synaptic connections onto Vm2 vulval muscles and the VC5 motor neurons. Cholinergic 
VC4 and VC5 motor neurons make synaptic connections onto the vulval muscles. 
Neurosecretory uv1 cells express several neuromodulators but do not have direct 
postsynaptic targets. Circles represent putative inhibitory connections while arrows 
denote excitatory connections. Solid lines depict known synaptic connections while 
dashed lines depict putative extrasynaptic signaling. Connections based on (Schafer, 
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2006, White et al., 1986, Zhang et al., 2008, Collins and Koelle, 2013). (B) Quantification 
of eggs in utero for wild type and transgenic animals (ufIs160) stably expressing the 
histamine-gated chloride channel in uv1 cells (uv1::HisCl1) under control conditions or 
immediately following exposure (6 hrs) to exogenous histamine (50 mM). uv1::HisCl1 
refers to expression of the Pocr-2::HisCl1::SL2::GFP::ocr-2 3’ UTR transgene. Bars 
represent mean ± SEM for each condition. Numbers in bars indicate n for each condition. 
****p<0.0001, ANOVA with Sidak’s test. (C) Temporal analysis of egg-laying behavior 
with uv1 silencing. Histamine exposure began 1 hr prior to the start of analysis and 
continued throughout. Tick marks indicate single egg-laying events. Representative data 
from one animal is shown for each condition. (D) Cumulative distribution of intercluster 
intervals between egg-laying events. The frequency of all intervals >300 s is plotted for 
the conditions indicated. Histamine treatment (light blue) produces a significant leftward 
shift toward shorter intercluster intervals. WT (– his): n=42; WT (+ his): n=38; uv1::HisCl1 
(-His): n=52, uv1::HisCl1 (+His): n=40. **p<0.01, Mann-Whitney test. n=number of 
intervals. 
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Figure II-2. Acute stimulation of uv1 cells inhibits egg-laying activity 
(A) Temporal analysis of egg-laying behavior for 400 s immediately following 
photostimulation of animals stably expressing ChR2 in the uv1 cells (vsIs189; Pocr-
2::ChR2::YFP::ocr-2 3’UTR) under control conditions (-ATR) or with exposure to 
exogenous retinal (+ATR). Light stimulation (indicated by arrow) (5 s, 100 W/m2) was 
initiated immediately after the first egg-laying event of an active phase. Tick marks 
indicate single egg-laying events. Representative data from 8 animals for each condition 
	 65	
is shown. Blue shading indicates the 0-20 s time interval quantified in Figure 2B (0-20). 
Two time periods are shown: (1) 50 s immediately following the first egg-laying event (0-
50) and (2) the subsequent 350 s (50-400) on a condensed scale. (B) Quantification of 
time interval between the onset of light stimulus and subsequent egg-laying event. 
Percent of animals responding within 20 s, 20-300 s, or after >300 s is shown as indicated. 
-ATR: n=9, +ATR: n=12, p<0.0001, Chi-square test. (C) Quantification of total egg-laying 
events following the initial event within an active phase. Percent of animals laying 0-2, 3-
5, or >5 eggs is shown as indicated. -ATR: n=9, +ATR: n=12, p<0.0001, Chi-square test.  
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Figure II-3. NLP-7 and FLP-11 are expressed in uv1 cells and act synergistically to 
inhibit egg-laying 
(A) Schematic of egg-laying neuromusculature. (B) Fluorescent images of adult 
hermaphrodites expressing either Pnlp-7::NLP-7::SL2::mCherry or Pflp-11::GFP reporter 
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transgenes. In addition to the egg-laying circuit, both reporters label head and tail neurons 
(see Figures S1 and S2). Scale bars, 5 µm. (C) Representative DIC images of wild type 
(upper) and nlp-7(lf);flp-11(lf) double mutants (lower). Arrows indicate position of the 
vulva. (D) Quantification of eggs in utero. Bars represent mean ± SEM for each genotype. 
Numbers in bars indicate the n for each group. **** p<0.0001, *** p<0.001 ANOVA with 
Sidak’s post-hoc test. In this and all subsequent figures, nlp-7(lf) and flp-11(lf) refer to the 
tm2984 and tm2709 alleles respectively. (E) Time interval between light stimulus and 
subsequent egg-laying event. For E and F, light stimulation (5 s, 100 W/m2) of animals 
stably expressing uv1::ChR2 was initiated immediately after the first egg-laying event of 
an active phase. Percent of animals that perform a second egg laying event  within 20 s, 
20-300 s, or after >300 s is indicated. control, n=12; nlp-7;flp-11, n=11. p<0.0001, Chi-
square test. Dashed lines indicate percent of animals in each category for control 
stimulation in the absence of retinal (from Figure 2). (F) Quantification of total egg-laying 
events following the initial event within an active phase. Percent of animals laying 0-2, 3-
5, or >5 eggs following uv1 photostimulation is shown. Dashed lines indicated percent of 
animals in each category for control stimulation in the absence of retinal (from Figure 2). 
ATR, exogenous retinal. control, n=12; nlp-7;flp-11, n=11. p<0.0001, Chi-square test. 
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Figure II-4. The duration of inactive egg-laying periods is reduced with combined 
deletion of nlp-7 and flp-11 
(A) Temporal analysis of egg-laying behavior. Tick marks indicate single egg-laying 
events. Representative data from one animal of each genotype is shown. (B) Histograms 
of intervals between egg-laying events. Intervals are plotted on a natural log scale on the 
x-axis and their relative frequencies are plotted on the y-axis. Red indicates intracluster 
intervals (<300 s) and blue indicates intercluster intervals (>300 s). Dashed lines indicate 
curve fit to Gaussian distribution. Mean intracluster and intercluster intervals for each 
genotype were calculated from the curve fit (wild type: 5.8 ± 1 s and 18.0 ± 0.02 mins; 
nlp-7(lf): 4.8 ± 1 s and 17.3 ± 0.02 mins; flp-11(lf): 4.1 ± 1 s and 21.4 ± 0.02 mins; nlp-
7(lf);flp-11(lf): 5.2 ± 1 s and 11.5 ± 0.02 mins). wild type: n1=144, n2=42; nlp-7(lf): n1=93, 
n2=30; flp-11(lf): n1=113, n2=32; nlp-7(lf);flp-11(lf): n1=114, n2=54. n1 = number of 
intracluster intervals (<300 s), n2 = number of intercluster intervals (>300 s). ***p<0.001, 
*p<0.05, Kruskal Wallis test with Dunn’s multiple comparisons test. The average 
intercluster interval (inactive phase) is significantly shortened in nlp-7;flp-11 double 
mutants and egg-laying occurs at earlier developmental stages compared with wild type. 
These effects are rescued by uv1-specific expression of either nlp-7 or flp-11 (see Figure 
S3). 
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Figure II-5. NLP-7 expression in the uv1 cells is required for the inhibition of egg-
laying 
(A) Representative DIC images of wild type (upper) and transgenic animals (ufIs118) 
stably expressing high levels of nlp-7 genomic sequence (NLP-7 OE, lower). Arrows 
indicate position of the vulva. (B) Quantification of eggs in utero. Bars represent the mean 
± SEM for each genotype. n≥20 for all measurements. ****p<0.0001, ANOVA with Sidak’s 
post hoc test. (C) Cumulative number of eggs laid over time in transgenic animals 
expressing the nlp-7 genomic sequence under control of a heat shock promoter 
(Phsp16.2::NLP-7 OE) or control animals (non-transgenic siblings). Animals were either 
(i) maintained continuously at 20°C or (ii) exposed to heat shock (33°C, 30 mins). *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001, t-test with Holm-Sidak’s correction for multiple 
comparisons. Gray shading indicates the timing and duration of heat shock. (D-I) 
Distribution of the developmental stages of eggs laid by either wild type adult 
hermaphrodites (D), or animals overexpressing nlp-7 from a 3.5 kb nlp-7 promoter (E), a 
2.5 kb nlp-7 promoter in which uv1 and VC fluorescence is not observed (F), a 2.5 kb nlp-
7 promoter in which uv1 and VC fluorescence is observed (G), a VC neuron specific 
promoter (Plin-11::pes-10) (H), or a uv1 promoter (ocr-2) (I). Animals overexpressing 
NLP-7 from the 3.5 kb promoter (E) lay a significantly higher fraction of late-stage 
embryos compared with wild type (p<0.0001, Fisher’s exact test). Exclusive expression 
in head and tail neurons produces no significant change (F), while there is a significant 
shift to later developmental stages when fluorescence is observed near the vulva (G) 
(p<0.0001, Fisher’s exact test). uv1-specific expression also produces a significant shift 
(p<0.0001, Fisher’s exact test) while VC-specific expression produces no significant 
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difference. For each genotype, eggs laid within a 30 minute time period were evaluated. 
See also Figure S3. 
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Figure II-6. NLP-7 and FLP-11 regulate the activity of the egg-laying circuit. 
(A) Schematic diagram depicting optogenetic stimulation of the HSN neurons. 
Photostimulation of channelrhodopsin expressed in the HSNs (Pegl-6a::ChR2::YFP) 
elicits bouts of egg-laying (Emtage et al., 2012)(Movie S3). (B) Cumulative fraction of 
animals that respond to blue light exposure over time. Latency to initial egg-laying event 
following light stimulus for varying light intensities. n=10 for each condition. –ATR refers 
to control stimulation (50 W/m2) of the same genotype in the absence of retinal. (C) 
Cumulative plot of latency to initial egg-laying event following light stimulus (20 W/m2). 
Wild type, n=20; flp-11(lf), n=16; nlp-7(lf), n=14; nlp-7(lf);flp-11(lf), n=20. **p<0.01, 
Wilcoxon matched-pairs test. (D) Cumulative plot of latency to initial egg-laying event 
following light stimulus (20 W/m2). ***p<0.001, Wilcoxon matched-pairs test. 
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Figure II-7. NLP-7 reduces the activity of the HSNs 
(A) Quantification of eggs laid in 1 hour for the genotypes indicated, in either control buffer 
or in the presence of exogenous serotonin (7.5 mg/ml). Bars represent mean ± SEM for 
each condition. Numbers above bars indicate n for each condition. ****p<0.0001 ANOVA 
with Sidak’s post hoc test. For A and B, egl-1 mutants in which the HSNs fail to develop 
are included as a control. 5-HT=serotonin. See also Figure S4 for comparison with egg-
laying on plates. (B) Quantification of eggs laid in 1 hour for the genotypes indicated in 
either control buffer or in the presence of the serotonin reuptake inhibitor fluoxetine (0.5 
mg/ml). Bars represent mean ± SEM for each condition. Numbers above bars indicate n 
for each condition. **p<0.01, ****p<0.0001 ANOVA with Sidak’s post hoc test. (C) 
Schematic of genetic manipulations used to modify egg-laying activity. See text for 
details. (D) Quantification of eggs in utero. Bars represent the mean ± SEM for each 
genotype. n≥20 for all measurements. ****p<0.0001, ANOVA with Sidak’s post hoc test. 
(E) Cumulative plot of latency to initial egg-laying event following light stimulus (50 W/m2) 
the genotypes indicated expressing Pegl-6a::ChR2::YFP. n≥15 for all measurements. 
***p<0.001, Wilcoxon matched pair test. (F) Quantification of eggs retained in utero. Bars 
represent mean ± SEM for each genotype. L-AChR(gf) refers to stable muscle-specific 
expression of AChRs with elevated ACh responsiveness (Bhattacharya et al., 2014). 
n≥15, ****p<0.0001, ANOVA with Sidak’s post hoc test.  
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Figure II-8. NLP-7 signaling regulates SNB-1::GFP abundance at HSN synapses 
(A) Left, confocal image of HSN cell body and synaptic regions. Dashed white box 
indicates approximate area of synaptic regions detailed at right and used for analysis. 
Right, representative confocal images of HSN presynaptic varicosities in transgenic 
animals expressing the synaptic vesicle marker SNB-1::GFP and DsRed2 in the HSNs 
(vsIs103, Ptph-1::SNB-1::GFP; Ptph-1::DsRed2) (Tanis et al., 2008) for the genotypes 
indicated. (B, C) Quantification of average SNB-1::GFP (B) or DsRed2 (C) intensity in 
synaptic region of the HSNs for the genotypes indicated. Bars represent mean ± SEM for 
each condition. See also Figures S5 and S6 for additional quantification of SNB-1::GFP 
and the active zone marker GFP::SYD-2. SNB-1::GFP fluorescent intensity is significantly 
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increased or decreased in HSN synaptic regions of nlp-7 mutants or NLP-7 OE animals 
respectively (see model in Figure S7). Numbers in bars indicate the n for each condition. 
*p<0.05, **p<0.01, ANOVA with Sidak’s post hoc test. Scale bar, 7 µm.  
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Figure II-9. nlp-7 gene structure, mutation and expression 
(A) Representative confocal images showing distribution of the dense core vesicle marker 
IDA-1::GFP (green) in a single uv1 cell. IDA-1::GFP shows a punctate distribution and is 
enriched near the cell periphery. Scale bar, 2 µm. (B) Fluorescent images of whole 
animals expressing Pnlp-7::nlp-7::SL2::mCherry. Scale bar, 100 µm. (C) Representative 
confocal images showing coexpression of Pnlp-7::SL2::mCherry with Pida-1::IDA-1::GFP 
in the uv1 cells, VC4 and VC5 motor neurons. Scale bar, 5 µm. (D) nlp-7 gene structure. 
Solid boxes represent exons. Sequences deleted in tm2984 allele are indicated. 
Predicted peptide products are shown to the right of corresponding gene models. 
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Figure II-10. flp-11 gene structure, mutation and expression 
(A) Fluorescent confocal images of whole animals expressing Pflp-11::GFP. Scale bar, 
100 µm. (B) flp-11 gene structure. Solid boxes represent exons. Sequences deleted in 
tm2706 allele are indicated. Predicted peptide products are shown to the right of 
corresponding gene models. 
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Figure II-11. uv-1-specific expression of flp-11 reverses constitutive egg-laying in 
nlp-7;flp-11 double mutants 
Distribution of the developmental stages of eggs laid by either nlp-7;flp-11 double mutants 
(upper) or with uv1-specific expression of either flp-11 (middle) or nlp-7 (lower) in nlp-
7;flp-11 double mutants. uv1-specific expression of either precursor produced a 
significant decrease in the proportion of eggs that were laid as 1-8 cell embryos. 
p<0.0001, Fisher’s exact test. 
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Figure II-12. Comparison of egg-laying rate in M9 versus plates 
Quantification of eggs laid in 1 hour for the genotypes indicated, in either control buffer 
(M9) or on NGM plates seeded with a thin bacterial lawn. Bars represent mean ± SEM 
for each condition. Numbers above bars indicate n for each condition. Data for M9 were 
duplicated from Figure 7. 
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Figure II-13. Characterization of synapses and cell bodies of HSNs 
(A, B) Quantification of total SNB-1::GFP volume (A) and number of SNB-1::GFP 
varicosities (B) in HSN synaptic regions for the genotypes indicated. SNB-1::GFP volume 
greater then 1 µm3 was considered as a varicosity (Tanis et al., 2008). (C) Representative 
confocal images of HSN cell bodies in transgenic animals expressing the synaptic vesicle 
marker SNB-1::GFP and DsRed2 in the HSNs (vsIs103, Ptph-1::SNB-1::GFP; Ptph-
1::DsRed2) for the genotypes indicated. Scale bar, 3 µm. (D, E) Quantification of average 
SNB-1::GFP (D) or DsRed2 (E) intensity in cell bodies of the HSNs for the genotypes 
indicated. Bars represent mean ± SEM for each condition. Numbers in bars indicate the 
n for each condition. *p<0.05, ANOVA with Sidak’s test. 
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Figure II-14. Localization of active zone marker SYD-2 in HSNs 
(A) Representative confocal images of HSN synapses in transgenic animals expressing 
the active zone marker GFP::SYD-2 in the HSNs (wyIs12, Punc-86::GFP::SYD-2; Podr-
1::GFP) for the genotypes indicated. Scale bar, 3 µm. (B, C) Quantification of average 
GFP::SYD-2 intensity (B) or number of SYD-2 clusters (C) in the HSN synaptic region for 
the genotypes indicated. Bars represent mean ± SEM for each condition. Numbers in 
bars indicate the n for each condition. 
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Figure II-15. NLP-7 and FLP-11 shape the timing of egg-laying through negative 
regulation of serotonergic HSN signaling 
(A) During the uv1 “off” phase, spontaneous activity of the HSN neurons elicits serotonin 
release onto the Vm2 vulval muscles, triggering entry into an active phase of egg-laying. 
Reduced levels of uv1 activity promote “short” inactive phases (bottom). (B) During the 
uv1 “on” phase, activation of the uv1 cells triggers release of NLP-7 and FLP-11 peptides. 
Release of these peptides promotes the termination of an active phase and lengthens the 
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duration of the inactive phase (bottom), at least in part, by reducing serotonergic 
activation of vulval muscles. Under normal (favorable) conditions, cycles of uv1 activity 
shape the timing of egg-laying events. Solid lines indicate synaptic connections. Dashed 
lines indicate volume transmission. Arrows indicate excitation. Circles indicate inhibition. 
In the lower panel of A and B, each tick mark represents a single egg-laying event.  
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Movie II-1. Egg-laying response to uv1 photostimulation 
Light stimulation of the uv1 cells inhibits egg-laying in a control animal expressing Pocr-
2::ChR2::YFP::ocr-2 3’UTR. Egg-laying events are indicated by numbers. Light 
stimulation is initiated immediately following the first egg-laying event. The timing and 
duration of blue light are indicated by blue text. The animal performs an avoidance 
response upon blue light exposure, likely due to ChR2 expression in 2-3 head sensory 
neurons (see Methods). Video is played 6X faster than real time. 
 
Movie II-2. Egg-laying response to uv1 photostimulation 
nlp-7(lf);flp-11(lf) double mutant animal expressing channelrhodopsin in the uv1 cells 
continues egg-laying following light stimulation of the uv1 cells. Note that the avoidance 
response to light stimulation is unaffected by combined deletion of nlp-7 and flp-11, 
indicating that NLP-7 and FLP-11 peptides are required for inhibition of the egg-laying 
response but not for the execution of the avoidance behavior. Egg-laying events are 
indicated by numbers (black). Light stimulation is initiated immediately following the first 
egg-laying event. The timing and duration of stimulation are indicated by blue text. Video 
is played 6X faster than real time. 
 
Movie II-3. Egg-laying response to HSN photostimulation 
Light stimulation of the HSNs in a control animal expressing Pegl-6a::ChR2::YFP. Timing 
of light stimulation is indicated by white text. The animal initiates a burst of egg-laying a 
few seconds following the onset of light stimulation. 
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Preface for Chapter III 
 
The work presented in this chapter elucidates the downstream signaling machinery 
involved in neuropeptide mediated inhibition of egg-laying behavior in C. elegans. The 
results shown in chapter II had demonstrated a role for the neuropeptides NLP-7 and 
FLP-11 in regulating serotonergic transmission to control the duration of distinct states in 
the egg-laying behavioral program. This chapter is an attempt to decode the molecular 
signaling candidates that mediate the actions of the two neuropeptides. A candidate 
genetic suppressor screen has identified some of the molecular signals that may act as 
receptors for the neuropeptides. In addition, a EMS mutagenesis screen has also 
identified a suppressor allele that may be one of the downstream effectors involved in the 
inhibitory effects of the neuropeptides.  
 Navonil Banerjee designed and performed the experiments and analyzed the data. 
Navonil Banerjee generated transgenic strains. The work presented in this chapter is a 
work in progress at the time of thesis preparation.  
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Abstract 
 
 Neuropeptide signaling play critical roles in establishing stable behavioral states 
and coordinating transitions between them. However, identifying the molecular 
candidates that mediate the actions of neuropeptides in vivo has largely remained a 
challenge. By studying neuropeptidergic signaling in the context of C. elegans egg-laying 
behavior, we have made an attempt to elucidate downstream molecular candidates 
mediating the inhibitory effects of the neuropeptides NLP-7 and FLP-11 on egg-laying 
activity. We have performed a candidate genetic suppressor screen and have identified 
the GPCRs encoded by the genes npr-7, npr-8 and frpr-3, that might be acting as potential 
receptors for NLP-7 and FLP-11 in mediating their modulatory control on the egg-laying 
circuit. In addition, we have also performed a genome-wide EMS mutagenesis screen 
and have identified a strong suppressor of NLP-7 mediated inhibition of egg-laying. Future 
studies aimed at detailed characterization of the receptors as well as the suppressor 
would provide useful insights into in vivo mechanisms governing neuropeptide signaling 
that refines activity within the egg-laying circuit to shape the temporal pattern of egg-
laying behavior. 
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Introduction 
 
 Neuropeptide signaling has been implicated in the temporal control of several 
behavioral programs. However, elucidating the downstream signaling mechanisms by 
which neuropeptides exert their effects on neural circuits remains a challenge. A critical 
step in elucidating mechanisms mediating the actions of neuropeptides is identifying their 
respective receptors. G-protein coupled receptors (GPCRs) have been largely attributed 
for mediating neuropeptidergic signaling.  GPCRs have slower kinetics of action and are 
therefore more suitable for generating stable and long-lasting behavioral states.  
 The functional characterization of neuropeptide GPCRs has been expedited by the 
use of C. elegans as a model system. Availability of genetic mutants as well as ease of 
generating reporter transgenics have shed light on the respective functions and 
expression patterns of several candidate GPCRs. Of all the protein coding genes in the 
C. elegans genome, around 7% encode GPCRs (Bargmann, 1998; Fredriksson and 
Schioth, 2005). GPCRs in C. elegans have been shown to mediate several behavioral 
outcomes ranging from locomotion or reproduction to social behavior.  
 GPCR signaling mechanisms in C. elegans are remarkably conserved with that in 
mammals. In the classical GPCR signaling pathway, the inactive receptor is bound to the 
Gabg heterotrimeric protein. Upon activation by its corresponding ligand, the 
Gabg dissociates into a GTP bound Ga (Ga-GTP) and a Gbg subunit. Ga-GTP activates 
different effectors such as phospholipase Cb (PLCb) or adenylyl cyclase depending on 
the Ga subtype. The Gbg subunit also regulates certain downstream effector proteins such 
as ion channels or PLCb (Figure III-1). 
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 However, lack of sequence similarity of neuropeptide GPCRs in C. elegans with 
vertebrate or insect GPCRs have limited the identification of candidate GPCRs 
responsible for neuropeptidergic signaling in C. elegans. A few approaches have been 
successful in matching GPCRs with their activating neuropeptide ligands. One approach 
had taken advantage of reverse pharmacology – expressing candidate GPCRs in 
heterologous systems and screening for activation with libraries of ligands (Mertens et 
al., 2004; Beets et al., 2011). Another approach in predicting neuropeptide GPCRs is to 
use all deorphanized GPCRs as a seeding set in a Multiple Expectation Maximization for 
Motif Elicitation/Motif Alignment and Search Tool (MEME/MAST) analysis (Jannsen et al., 
2010; Frooninckx et al., 2012). Using this approach, a list of 99 genes encoding 125 
putative neuropeptide GPCRs have been identified and 23 GPCRs have been 
deorphanized till date.  
 We had previously identified two neuropeptides encoded by the genes nlp-7 and 
flp-11 that are involved in regulating the temporal organization of C. elegans egg-laying 
behavior. Here, we make an attempt to identify the receptor(s) for these neuropeptides 
and elucidate the underlying downstream signaling machinery responsible for mediating 
their actions.         
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Results 
 
A candidate genetic screen to identify receptors mediating NLP-7 and FLP-11 
inhibition of egg-laying. 
 In Chapter II, we had shown that local neuromodulation by a group of 
neurosecretory cells (uv1) direct the timing of egg-laying events. These effects are 
primarily mediated by neuropeptides encoded by the genes – nlp-7 and flp-11, that inhibit 
serotonin release from the HSN motorneurons and prolong the duration of inactive 
phases in the egg-laying behavioral program. To understand how the behavioral effects 
of these neuropeptides are encoded at a molecular level, we have performed a candidate 
genetic suppressor screen to identify potential GPCRs that act downstream of these 
neuropeptides.  
 Based on our previous results, we have found that overexpression of NLP-7 (NLP-
7 OE) leads to a chronic inhibition of egg-laying and over time, leads to a severe egg-
laying defect. Here, we use this strong egg-laying defective phenotype of NLP-7 OE 
animals as a tool to unravel downstream molecular pathways mediating its action. We 
had demonstrated that the egg-laying defect of NLP-7 OE animals was partially 
suppressed by a loss-of-function mutation in egl-47, which encodes a transmembrane 
protein bearing homology to the Drosophila gustatory receptor family of proteins 
(Bargmann, 2006). Although EGL-47 was previously thought to be a GPCR (Moresco and 
Koelle, 2004), later studies had predicted that it displays an inverted membrane topology 
compared with conventional GPCRs (Bargmann, 2006) and may function as a chloride 
channel (Tanis et al., 2009). We searched for candidate GPCR loss-of-function mutants 
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that suppress the residual egg-laying defective phenotype of egl-47(lf);NLP-7 OE 
animals. This approach was further supported by our previous findings that a loss-of-
function mutation in goa-1, the C. elegans ortholog of the mammalian Gai subunit, 
completely suppresses the residual egg-laying defect of egl-47(lf);NLP-7 OE animals. Our 
working hypothesis was that the GPCR(s) which could act as potential receptor(s) for nlp-
7 encoded peptides, would most likely be associated with the inhibitory G-protein subunit 
GOA-1. Consequently, that GPCR would function in the same genetic pathway as GOA-
1, and would presumably lead to complete suppression of the egg-laying defect of egl-
47(lf);NLP-7 OE animals.  
 A previous study had listed 99 genes encoding GPCRs that may act as putative 
neuropeptide receptors (Jannsen et al., 2010). We selected our candidates from that list 
of GPCRs and crossed loss-of-function GPCR mutants into the egl-47(lf);NLP-7 OE 
strain. To look for candidate suppressors, we quantified the number of eggs in utero. We 
found that loss-of-function mutations in npr-7 and npr-8 partially suppressed the residual 
egg-laying defect of egl-47(lf);NLP-7 OE animals. Both npr-7(lf);egl-47(lf);NLP-7 OE and 
npr-8(lf);egl-46(lf);NLP-7 OE  transgenic animals retained a number of eggs in utero that 
was intermediate between wild type and egl-47(lf);NLP-7 OE animals. While wild type 
animals typically retained 15 eggs on average and egl-47(lf);NLP-7 OE  animals retained 
29 ± 1 eggs in utero under favorable conditions, npr-7(lf);egl-47(lf);NLP-7 OE and npr-
8(lf);egl-47(lf);NLP-7 OE retained about 21 and 22 eggs respectively (Figure III-2). These 
results indicate that NPR-7 and NPR-8 could act as potential receptors for NLP-7 
mediated inhibition of egg-laying. Both of these receptors fall under the category of 
rhodopsin family of GPCRs and show resemblance to neuropeptide Y-like GPCRs in 
	 96	
insects and mammals (Frooninckx et al., 2012). NPR-7 had been previously shown to 
play a role in fat metabolism and locomotion in C. elegans (Keating et al., 2003; Cohen 
et al., 2009) but any roles of NPR-7 and NPR-8 with regard to egg-laying behavior has 
not been demonstrated. Both npr-7(lf) and npr-8(lf) mutants do not show appreciable 
changes in the number of eggs retained in utero (Figure III-2) which suggests that they 
may act redundantly with each other or some other protein. Moreover, this does not rule 
out the possibility that they may play roles in other aspects of reproductive behavior such 
as regulating brood size. The cognate ligands for either receptor has not been elucidated 
yet. It remains to be seen whether peptide encoded by nlp-7 could activate NPR-7 and/or 
NPR-8 in a heterologous system. Further, it would be interesting to know where do these 
receptors function to mediate NLP-7 inhibition of egg-laying. A crucial step would be to 
determine the expression patterns of these receptors and performing cell-specific rescue 
experiments to elucidate their sites of action.  
  
The GPCR FRPR-3 may be involved in FLP-11 mediated inhibition of egg-laying 
 We have not been able to adopt a similar approach to identify potential receptors 
involved in FLP-11 mediated inhibition of egg-laying because unlike NLP-7 OE, 
overexpression of FLP-11 did not lead to a strong egg-laying defective phenotype. 
However, in the candidate screen described above, we found that loss-of-function 
mutation in the GPCR encoded by frpr-3 completely suppressed the residual egg-laying 
defect of egl-47(lf);NLP-7 OE animals. frpr-3(lf); egl-47(lf);NLP-7 OE animals retained 
around 15 eggs in utero, similar to wild type (Figure III-3). FRPR-3 belongs to the 
rhodopsin family of GPCRs and resembles RFamide family of peptide receptors. 
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Interestingly, FRPR-3 has been previously demonstrated to be activated by peptides 
encoded by flp-11 using cellular fluorescent assay in a heterologous system (Mertens et 
al., 2004). We had already shown that flp-11 acts in a parallel genetic pathway to nlp-7 
since nlp-7(lf);flp-11(lf) double mutants exhibit a strong egg-laying constitutive phenotype 
(Figure III-3) whereas neither nlp-7(lf) or flp-11(lf) single mutants show any obvious egg-
laying phenotype. We therefore hypothesized that FLP-11 may inhibit egg-laying by 
acting on the FRPR-3 receptor and this pathway acts in parallel to NLP-7 signaling 
pathway. In support of this idea, we found that flp-11(lf) mutants also completely suppress 
the residual egg-laying defect of egl-47(lf);NLP-7 OE animals (Figure III-3). Moreover, 
nlp-7(lf);frpr-3(lf) double mutants display a significant egg-laying constitutive phenotype 
and closely phenocopy nlp-7(lf);flp-11(lf) double mutants with regard to the developmental 
stages of embryos laid during egg-laying (Figure III-3). For instance, nlp-7(lf);flp-11(lf) 
double mutants lay around 58% of their eggs in the early stages of development (1-8 cell 
stage). Similarly, nlp-7(lf);frpr-3(lf) double mutants lay around 45% of early-stage 
embryos. None of nlp-7(lf), flp-11(lf) or frpr-3(lf) single mutants show any obvious change 
in the developmental stage of embryos laid. Together, these results indicate that FLP-11 
peptides may inhibit egg-laying by acting through the FRPR-3 receptor and likely act in a 
parallel genetic pathway with NLP-7 signaling. 
 To understand where FRPR-3 is endogenously expressed, we used a reporter 
construct in which coding sequence for the fluorescent protein mCherry preceded by the 
SL2 splice leader was added to the native frpr-3 genomic locus that included ~10kb of 
promoter and the genomic sequence. This bicistronic vector drives expression of the 
precursor and the mCherry reporter under the control of native regulatory sequences. By 
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examining mCherry fluorescence, we found that frpr-3 was expressed in several neurons 
near the head and a few neurons in the tail region. However, no detectable mCherry 
fluorescence was observed near the vulva (not shown).  
 
A forward genetic screen to identify downstream regulators of NLP-7 signaling 
 As described previously, NLP-7 OE animals produced a robust egg-laying 
defective phenotype. We used this as a tool to identify downstream signaling components 
that might be mediating the inhibitory effects of NLP-7. We had previously demonstrated 
that egl-47(lf) partially suppressed the egg-laying defect of NLP-7 OE. Therefore, to 
identify additional suppressors of NLP-7 overexpression induced egg-laying defect, we 
performed a forward genetic screen using the egl-47(lf);NLP-7 OE as the starting strain. 
egl-47(lf);NLP-7 OE animals exhibited an egg-laying defective phenotype that was 
intermediate between wild type and NLP-7 OE animals. We mutagenized egl-47(lf);NLP-
7 OE animals and screened their F2 progeny for suppression of the egg-laying defect. Of 
the animals screened, we found one suppressor (uf166) that showed the strongest and 
most consistent suppression of the egg-laying defect of egl-47(lf);NLP-7 OE animals. We 
quantified the number of eggs in utero as a measure of egg-laying. uf166;egl-47(lf);NLP-
7 OE animals retained around 13 eggs in the uterus, similar to wild type and significantly 
less than egl-47(lf);NLP-7 OE animals (Figure III-4). We genetically isolated the 
suppressor (ufIs166) from egl-47(lf) mutation and NLP-7 OE array (ufIs118) and found 
that it displayed a strong egg-laying constitutive phenotype (not shown). uf166 animals 
retained around 5 eggs in utero compared to 15 eggs in the wild type. Reduction in the 
number of eggs in utero may also indicate reduced production of eggs. To address this 
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question, we analyzed the developmental stage of embryos laid by uf166 animals and 
found that there was a significant increase in the fraction of early stage embryos. This 
suggests that animals carrying the uf166 mutation displayed an increase in the rate of 
egg-laying. It would be crucial to map the position of the allele in the genome and identify 
the mutation by whole genome sequencing. Identifying the genetic suppressor allele 
would likely lead to uncovering a key signaling component involved in NLP-7 mediated 
inhibition of egg-laying behavior.     
 
A loss-of-function mutation in the potassium chloride cotransporter KCC-2 
completely suppresses the egg-laying defect of NLP-7 OE    
 Prior work had demonstrated that a loss-of-function mutation in the gene encoding 
a potassium chloride cotransporter kcc-2, suppressed the egg-laying defect caused by a 
gain-of-function mutation in egl-47, thus indicating the possibility that EGL-47 might act 
as a chloride channel or may activate some other chloride channel(s) (Tanis et al., 2009). 
Interestingly, we had demonstrated that a loss-of-function mutation in egl-47 partially 
suppressed the egg-laying defect of NLP-7 OE (Figure III-2A). To test the possibility that 
the actions of NLP-7 might be dependent on chloride gradient, we tested egg-laying 
behavior in kcc-2(lf);NLP-7 OE animals. Strikingly, we found that loss-of-function mutation 
in kcc-2 completely suppressed the egg-laying defect of NLP-7 OE animals (Figure III-5). 
kcc-2(lf);NLP-7 OE animals retain similar number of eggs in utero as kcc-2(lf) mutants 
(Figure III-5A). A previous study had shown that kcc-2(lf) mutants were egg-laying 
constitutive and also were defective for egg production (Tanis et al., 2009). To test 
whether the suppression of egg-laying defect of NLP-7 OE animals by kcc-2(lf) mutants 
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was not due to decreased egg production, we assessed the developmental stage of 
embryos laid by kcc-2(lf);NLP-7 OE animals. kcc-2(lf) mutants lay ~40% of their eggs in 
early stages (1-8 cell stage) of development (Figure III-5B). We observed that kcc-
2(lf);NLP-7 OE animals laid a similar fraction of early stage embryos (Figure III-5C) 
indicating that kcc-2 mediated suppression of NLP-7 OE egg-laying defect was not due 
to decreased egg production. Together, our results suggest that the inhibitory actions of 
NLP-7 might, at least in part, dependent on the chloride gradient of the target cell.  
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Discussion 
 Neuropeptides play a central role in establishing stable behavioral states. 
However, elucidating the signaling machinery that mediate the actions of neuropeptides 
has remained a challenge. Identifying the signaling components involved in neuropeptide 
regulation of behavior would allow us to gain a fundamental understanding of how specific 
neuropeptide signaling pathways alter the activity of neural circuits at a cellular and 
molecular level. While previous works have demonstrated several potential mechanisms 
of neuropeptide action on neural circuit functioning, dissecting neuropeptide signaling 
mechanisms in vivo has largely remained a challenge. Here we have made an attempt to 
unravel the downstream signaling components involved in neuropeptide modulation of 
egg-laying behavior. By using powerful genetics, we have been able to identify some of 
the signaling components that mediate the in vivo actions of specific neuropeptides in the 
context of circuits where they are endogenously released.  
  Our study has focused on identifying the candidate receptor(s) involved in 
mediating the inhibitory effects of the neuropeptides NLP-7 and FLP-11 on egg-laying 
behavior. We had previously demonstrated that the coordinated actions of NLP-7 and 
FLP-11 establish the temporal organization of egg-laying by setting the duration of 
inactive phases (see Chapter II). These effects are, at least in part, achieved by regulating 
serotonergic transmission between the HSN motorneurons and vulval muscles. However, 
our findings have been limited by the lack of potential receptor(s) that are involved in NLP-
7 and FLP-11 signaling. Here, we have performed a candidate genetic suppressor screen 
using candidate GPCRs that have been predicted to act as neuropeptide receptors. So 
far, we have identified the GPCRs encoded by the npr-7 and npr-8 genes that partially 
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suppress the egg-laying defect of NLP-7 overexpressing animals. The corresponding 
ligands for NPR-7 and NPR-8 have not been identified yet. It is possible that these 
receptors may mediate the inhibitory effects of NLP-7 on the egg-laying circuit. Thus, it 
would be interesting to see whether NLP-7 peptides could activate these GPCRs in a 
heterologous system. In addition, determining the cells which express these receptors by 
examining their respective expression patterns would allow us to elucidate the site(s) of 
action for NLP-7 peptides. We have also found that FRPR-3, a GPCR that is activated by 
FLP-11 peptides in human embryonic kidney (HEK) cells, also suppressed the egg-laying 
defect of NLP-7 OE animals. This raises the interesting possibility that FRPR-3 may also 
act as one of the potential receptors for NLP-7 mediated inhibition of egg-laying. It 
remains to be seen whether NLP-7 peptides could activate FRPR-3 in a heterologous 
system. Nevertheless, the genetic suppression of NLP-7 OE egg-laying defect by both 
flp-11 and frpr-3 likely indicates the existence of a genetic pathway mediated by FLP-11 
peptides acting via the FRPR-3 receptor that acts in parallel to the NLP-7 signaling 
pathway. Unlike FRPR-3 mediated suppression of egg-laying defect of NLP-7 OE 
animals, FRPR-4, which had also been shown to act as a potential FLP-11 receptor, do 
not show any obvious effect (Figure III-3), suggesting that the effects are specific to 
FRPR-3. There are two other candidate receptors of FLP-11 peptides – NPR-4 and NPR-
22. However, it remains to be seen whether these receptors are also involved in FLP-11 
mediated control of egg-laying.  
 Our genome-wide EMS mutagenesis screen has identified a candidate that also 
suppressed the residual egg-laying defect of egl-47(lf);NLP-7 OE animals. Genetic 
isolation of the suppressor has revealed that it exhibits an egg-laying constitutive 
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phenotype. We had previously shown that loss-of-function in goa-1 also suppressed the 
residual egg-laying defective phenotype of egl-47(lf);NLP-7 OE animals. To test whether 
the identified suppressor contains a mutation in the goa-1 gene, we sequenced the 
genomic locus of goa-1 from the start codon to stop codon. Sequencing analysis did not 
reveal any mutation within that region. Although we cannot rule out the possibility of the 
suppressor harboring any mutation in goa-1 promoter or regulatory sequences 
downstream of the stop codon, our results indicate that the effects of the suppressor allele 
in reversing the egg-laying defects of egl-47(lf);NLP-7 OE animals are not caused by a 
loss-of-function mutation in the goa-1 coding sequences. It would be interesting to 
perform whole-genome sequencing to reveal the identity of the mutant allele. This would 
potentially allow us to uncover one of the molecular candidates involved in 
neuromodulation of egg-laying mediated by NLP-7 and/or FLP-11.      
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Materials and Methods 
 
Strains 
All nematode strains were maintained at 20°C on agar nematode growth media plates 
seeded with E. Coli OP50.  The wild type reference animals for all cases are the N2 Bristol 
strain. The following strains were used or generated in this work: IZ1236: ufIs118 [Pnlp-
7::nlp-7::nlp-7 3’UTR, Plgc-11::GFP], RB850: egl-47(ok677)V, IZ1235: egl-
47(ok677);ufIs118, IC683: npr-9(tm1652), IZ2188: npr-9(tm1652);egl-47(ok677);ufIs118, 
XA3702: npr-2(ok419), IZ2202: npr-2(ok419);egl-47(ok677);ufIs118, RB1393: npr-
5(ok1583), IZ2203: npr-5(ok1583);egl-47(ok677);ufIs118, IZ1882: frpr-3(ok3302), 
IZ2204: frpr-3(ok3302);egl-47(ok677);ufIs118, RB1325: npr-10(ok1442), IZ2232: npr-
10(ok1442);egl-47(ok677);ufIs118, RB1329: npr-8(ok1446), IZ2217: npr-8(ok1446);egl-
47(ok677);ufIs118, RB1837: frpr-4(ok2376), IZ2260: frpr-4(ok2376);egl-
47(ok677);ufIs118, RB761: npr-7(ok527), IZ2259: npr-7(ok527);egl-47(ok677);ufIs118, 
IZ1005: ckr-1(ok2502), IZ1446: ckr-1(ok2502);egl-47(ok677);ufIs118, RB799: npr-
11(ok594), IZ2324: npr-11(ok594);egl-47(ok677);ufIs118, MT16665: egl-6(n4536), 
IZ2413: egl-6(n4536);egl-47(ok677);ufIs118, IZ1273: kcc-2(vs132);ufIs118, LX999: kcc-
2(vs132).  
 
Molecular Biology and Transgenes 
NLP-7 overexpression: The NLP-7 OE strain (ufIs118) was generated by microinjection 
and subsequent X-ray integration of a 5104 bp PCR product (injected at 100 ng/µl) 
containing the nlp-7 promoter (about 3.5 kb), genomic locus and the 3’UTR (-3448 bp to 
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+1656 bp relative to the transcriptional start) along with pHP6 (Plgc-11::GFP, 50 ng/µl) 
as coinjection marker. The integrated strain was outcrossed five times with wild type. 
 
Behavioral assays 
Quantification of eggs in uterus. Age-matched adults were obtained by collecting late 
fourth larval stage (L4) animals and culturing at 20°C for 30 hrs. For each strain analyzed, 
animals were individually dissolved in 25% sodium hypochlorite, and their eggs, which 
survived because of their protective eggshells, were quantified. 
 
Embryo staging assay. To score the developmental stage of newly laid eggs, age-
matched adults (30 hrs after the late L4 stage) were transferred to fresh nematode growth 
medium plates (15 animals per plate), allowed to lay eggs for 30 mins and removed. Eggs 
laid on the plates were examined by a high power dissecting microscope and categorized 
as described in Ringstad and Horvitz, 2008. 
 
EMS mutagenesis screen 
Egg-laying defective egl-47(lf);NLP-7 OE animals were mutagenized with 50mM ethyl 
methanesulphonate (Brenner, 1974). F2 progeny of ~1500 mutagenized animals were 
collected as fourth larval stage (L4) animals, washed twice with M9 buffer and transferred 
to fresh NGM agar plates. After ~36 hrs following the L4 stage, the animals were screened 
for suppression of the egg-laying defect and were individually transferred to single plates. 
The progeny from each plate were individually treated with 25% sodium hypochlorite and 
the eggs retained in the uterus were quantified. 
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Microscopy 
DIC imaging 
Worms were mounted on agarose pads and immobilized with 0.3 M sodium azide. All 
images were obtained from staged young adult animals (~30hrs after the L4 stage). 
Images were acquired using a Zeiss Axioskop 2 microscope system and LSM Pascal 5 
imaging software (Zeiss). 
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Figure III-1. The classical GPCR signaling pathway. G-protein signaling is highly 
conserved between C. elegans and mammals. On ligand binding, the receptor changes 
conformation followed by the exchange of GDP to GTP by guanine nucleotide exchange 
factor (GEF). The heterotrimeric G-protein dissociates from the receptor and splits into a 
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Ga-GTP and a Gbg subunit. The Ga-GTP subunit binds to different downstream 
effectors depending on the Ga subtype as indicated. G protein is terminated by 
internalization of the GPCR that is initiated by phosphorylation of the receptor by GPCR 
kinases. 
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Figure III-2. A candidate suppressor screen to identify receptor(s) for the 
neuropeptides NLP-7 and FLP-11. 
(A) Schematic for the genetic strategy of the suppressor screen. See text for details. (B) 
Quantification of eggs in utero for wild type, NLP-7 OE, egl-47(lf);NLP-7 OE  and gpcr(lf) 
mutants in the egl-47(lf);NLP-7 OE genetic background. Bars represent mean ± SEM for 
each genotype. n≥15 for all genotypes. **** p<0.0001, *** p<0.001 ANOVA with Sidak’s 
post-hoc test. (C) Quantification of eggs in utero for wild type and GPCR loss-of-function 
mutants used as candidates for the screen. Bars represent mean ± SEM for each 
genotype. n≥8 for all genotypes. **** p<0.0001, *** p<0.001 ANOVA with Sidak’s post-
hoc test. 
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Figure III-3. FLP-11 may act through its receptor FRPR-3 in a parallel genetic 
pathway to NLP-7 signaling. 
(A) Quantification of eggs in utero. Loss-of-function mutations in flp-11 and frpr-3 
suppress the residual egg-laying defect of egl-47(lf);NLP-7 OE animals. Bars represent 
mean ± SEM for each genotype. n≥15 for all genotypes. **** p<0.0001, ANOVA with 
Sidak’s post-hoc test. (B) Quantification of the developmental stage of embryos laid by 
animals of the indicated genotype. nlp-7(lf);frpr-3(lf) double mutants laid significantly 
higher percentage of embryos in the 1-8 cell stage than nlp-7(lf) or frpr-3(lf) single 
mutants. p<0.0001, Fisher’s exact test.      
wild type nlp-7(lf) 
flp-11(lf) frpr-3(lf) 
nlp-7(lf);flp-11(lf) nlp-7(lf);frpr-3(lf) 
A 
B C 
D E 
F G 
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Figure III-4: An EMS screen to identify downstream effectors of NLP-7 signaling. 
(A) Schematic showing the strategy for the EMS screen (see text for details). (B) DIC 
images of wild type, egl-47(lf);NLP-7 OE and uf166;egl-47(lf);NLP-7 OE animals. Note 
the decreased number of eggs in the uterus of uf166;egl-47(lf);NLP-7 OE animals. 
Asterisks denote position of the vulva. (C) Quantification of eggs in utero for the 
genotypes indicated. uf166;egl-47(lf);NLP-7 OE animals retain significantly fewer eggs in 
uterus compared to egl-47(lf);NLP-7 OE. uf166 animals are egg-laying constitutive. Bars 
represent mean ± SEM for each genotype. n≥15 for all genotypes. **** p<0.0001, ANOVA 
with Sidak’s post-hoc test.  
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Figure III-5: A loss-of-function in kcc-2 suppresses the egg-laying defect of NLP-7 
overexpression. (A) Quantification of eggs in utero for the genotypes indicated. Kcc-
2(lf);NLP-7 OE animals retain significantly fewer number of eggs in utero compared to 
NLP-7 OE animals. Bars represent mean ± SEM for each genotype. n≥15 for all 
genotypes. (**** p<0.0001, ANOVA with Sidak’s post-hoc test. ns = not significant). (B,C) 
Distribution of the developmental stages of eggs laid by kcc-2(lf) and kcc-2(lf);NLP-7 OE 
animals. kcc-2(lf);NLP-7 OE animals laid similar proportion of eggs in the early stages of 
development (1-8 cell stage) as kcc-2(lf) single mutants.     
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CHAPTER IV: DISCUSSION 
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Neuromodulatory control of behavioral states 
 
 To maximize their chances of survival, animals must constantly switch between 
different behavioral states and rapidly modify their durations in response to the changing 
environment as well as internal states. One of the most well-studied examples is sleep-
wake behavior. Sleep can be further subdivided into two phases – rapid eye movement 
sleep (REM) characterized by vivid dreams and non-REM sleep (NREM) with decreased 
sensation (Hobson, 2005). Similarly, wakefulness is also composed of quiet, inattentive 
and aroused, vigilant states. The underlying neural mechanisms controlling transitions 
between these component states are molecularly represented by neuromodulators. 
Neuromodulators enable neural circuits to rapidly change their activity patterns in a 
context-dependent manner. Typically, through modifications of neuronal excitability, 
dynamics and synaptic efficacy between components of a circuit, neuromodulators 
enable a fixed complement of neurons within a circuit to generate alternate activity 
patterns and consequently, give rise to opposing behavioral outcomes. It is crucial to gain 
a fundamental understanding of neuromodulatory mechanisms operating in vivo to 
establish distinct behavioral states and coordinate transitions between them.  
 The relative simplicity of its nervous system and amenability to powerful genetic 
analyses makes C. elegans a useful model to study neuromodulation. The behavioral 
program associated with egg-laying in C. elegans is composed of alternating behavioral 
states – active phase and inactive phase. However, the mechanisms that govern the 
timing of egg-laying had remained unaddressed. Previous work had shown that egg-
laying behavior is susceptible to changes in environmental conditions (Fenk and de Bono, 
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2015; Ringstad and Horvitz, 2008; Waggoner et al., 2000; Zhang et al., 2008). We 
demonstrate that egg-laying behavior is subject to neuromodulatory control even in the 
absence of any external stimuli. In Chapter II, we show that a group of neurosecretory 
cells (uv1) establish the timing of egg-laying events under favorable conditions by 
modulating the activity of a core neural circuit. Our study has also demonstrated a 
requirement of local neuromodulation in regulating egg-laying. We have identified the 
molecular candidates that mediate the neuromodulatory effects of uv1 cells. Two 
neuropeptides encoded by the nlp-7 and flp-11 genes are released by the uv1 cells and 
act locally to inhibit serotonergic transmission between the HSN motorneurons and vulval 
muscles, thereby preventing premature transitions from the inactive phase to the active 
phase of egg-laying.  
 Our observations indicate that the inhibitory actions of uv1 cells on egg-laying 
behavior are mediated by NLP-7 and FLP-11 peptides. However, the roles of these 
peptides on uv1 mediated inhibition are not complete (Figure II-2, II-3D), suggesting that 
other signaling molecules may also play a role. As described previously (Alkema et al., 
2005), the uv1 cells also express the monoamine transmitter tyramine and exogenous 
tyramine could halt egg-laying activity. It is possible that tyramine and these 
neuropeptides act cooperatively in the inhibition of egg-laying. We did some preliminary 
experiments to test this idea. We have quantified eggs in utero for tdc-1; nlp-7; flp-11 
triple mutant compared with the nlp-7; flp-11 double or either single mutant (Figure IV-1). 
We do not observe significant enhancement with mutations in tdc-1 or lgc-55 (candidate 
receptor for tyramine) using this approach. However, we are somewhat hesitant to draw 
firm conclusions from these negative data. As tyramine likely acts through the ligand-
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gated channel lgc-55 to affect egg-laying (Collins et al., 2016), it seems logical that the 
actions of tyramine may occur on a more rapid time scale that would not necessarily be 
reflected in our analysis. We therefore believe that a more complete exploration of 
tyramine interactions with neuropeptide signaling is warranted. A detailed analysis of the 
temporal dynamics of egg-laying may reveal an interesting synergy between the two 
modes of signaling systems.  
 Our results also indicated at least one of the potential mechanisms by which 
inhibition of serotonin release is achieved. We show that altering levels of the 
neuropeptide NLP-7 leads to changes in synaptic vesicle abundance in the HSN 
motorneurons. Although several plausible mechanisms could be responsible for such 
changes (see Chapter II Discussion), it would be interesting to see whether these effects 
are directly mediated by neuropeptides or whether they are a result of intrinsic feedback 
mechanism(s) in the HSN motorneurons in response to chronic changes in its activity. 
One way of testing this idea would be to temporally regulate the actions of these peptides 
by expressing them in an acute fashion under the control of a heat shock promoter and 
monitoring changes in synaptic vesicle abundance with time measured from the onset of 
heat shock.  Another potential mechanism by which these peptides might inhibit HSN 
activity is by reducing calcium flux into the HSNs. According to prior reports, calcium 
activity in the HSNs are tightly correlated with egg release from the vulva (Zhang et al., 
2008, Collins et al., 2016) and there is a significant reduction in the frequency of HSN 
calcium spikes during inactive periods of egg-laying compared with active phases (Collins 
et al., 2016). It is possible that neuropeptides encoded by nlp-7 and flp11 negatively 
regulate calcium activity in the HSNs during inactive phases of egg-laying and help to 
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maintain the appropriate duration of inactive phases. Measuring HSN calcium activity in 
vivo in freely behaving animals would be a good way to test this idea.  Our genetic 
analyses in Chapter II indicate that the effects of the peptides may not be limited to the 
HSNs. Therefore, it would also be intriguing to see whether peptidergic signaling 
mediated by NLP-7 and FLP-11 also affects the activities of other cells in the circuit, such 
as vulval muscles or the VC motorneurons. Addressing these questions would potentially 
provide useful insights into mechanisms underlying changes in levels of 
neurotransmission mediated by neuropeptidergic signaling under in vivo conditions.  
 Our findings in Chapter II were limited by the lack of knowledge about the potential 
neuropeptide receptors and downstream signaling components that mediate the actions 
of NLP-7 and FLP-11. In Chapter III, we have identified at least some of the molecules 
that may act as candidate receptors for the two neuropeptides. A crucial step forward 
would be to identify the cells where the receptors act to mediate the inhibitory actions of 
NLP-7 and FLP-11 on the egg-laying circuit. Deciphering the sites of action of the 
neuropeptides would allow us to gain a deeper understanding of the cellular mechanisms 
underlying in vivo actions of neuropeptides in modulating neural circuit activity.  
 Based on our findings in Chapter II and III, we propose a model where the 
coordinated actions of neuropeptides encoded by nlp-7 and flp-11 negatively regulate the 
activity of the motor circuit responsible for egg-laying behavior. Our powerful genetic 
analyses have provided some useful insights into the possible mechanism(s) of action of 
these peptides. We hypothesize that NLP-7 peptides inhibit the HSNs by at least two 
parallel mechanisms (Figure IV-2). One pathway involves activation of the seven trans-
membrane protein EGL-47, which through its predicted role as a regulator of chloride 
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channel(s), increases chloride flux into the HSNs resulting in its hyperpolarization and 
subsequent failure to promote egg-laying active phases. The other pathway involves 
activation of a yet unknown GPCR that is coupled to the Gao subunit GOA-1 which has 
been reported to inhibit serotonin release from the HSNs, thereby preventing the animal 
to enter active phases prematurely.    
 
Complexity of neuromodulatory networks in vivo 
 
 Neuromodulatory strategies are remarkably complex – single modulators act on 
multiple neurons and activate multiple receptors or single neurons can be modulated by 
multiple neuromodulators. Work done on neural circuits of crustaceans and mollusks for 
more than 40 years have shed light on the complexity of neuromodulatory signaling. In 
almost every situation, the activity of a single neural circuit is subject to the modulatory 
effects of several modulators making it extremely difficult to identify all the modulatory 
inputs to a given circuit. Therefore, decoding the rules of modulation in vivo in the context 
of complex neural circuits in vertebrates has remained a major challenge. In addition, 
linking the actions of neuromodulators in vivo with generation of distinct behaviors has 
largely remained unanswered. 
 One of the reasons why C. elegans has emerged as a useful model to study 
neuromodulation is the simplicity of its nervous system and the known connectivity 
diagram. Having a full knowledge of the anatomical wiring of the nervous system serves 
as a platform to study specific neuromodulatory mechanisms responsible for alterations 
of activity within a defined circuit. Studies on neuromodulation in C. elegans have 
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demonstrated some significant violations of the one neuron – one behavior rule. 
Neuromodulators have been shown to alter circuit composition in a context dependent 
manner and enable distinct populations of neurons to participate in a single behavior 
under different conditions. For example, octanol avoidance behavior is mediated solely 
by the ASH neurons under well-fed conditions. In contrast, starvation leads to distribution 
of this avoidance behavior between ASH, AWB and ADL neurons (Chao et al., 2004). 
Several neuromodulators such as serotonin, dopamine, tyramine, octopamine and 
several neuropeptides have been implicated in this change in circuit composition (Horvitz 
et al., 1982; Wragg et al., 2007; Mills et al., 2011). Single neuromodulatory signaling 
pathways have also been demonstrated to lead to multiple behavioral outputs. For 
example, neuropeptide signaling mediated by the NPR-1 receptor that regulates aerotaxis 
also affects a second behavior, aggregation of animals into feeding groups or social 
feeding (Chang et al., 2006; Macosko et al., 2009; Rogers et al., 2006; de Bono and 
Bargmann, 1998). The functional diversity of neuromodulatory pathways arises, in part, 
due to utilization of distinct receptors by the same neuromodulator in different subsets of 
neurons. For instance, part of the effect of serotonin on avoidance responses is mediated 
by a G-protein coupled serotonin receptor expressed in ASH sensory neurons whereas 
another part is mediated by a serotonin gated ion channel in interneurons (Harris et al., 
2009). Further, the neuropeptide FLP-18 acts on the NPR-4 receptor in AVA and RIV 
neurons to modulate chemosensory responses and foraging behavior, whereas it 
regulates dauer formation by activation of NPR-5 in ASJ neurons (Cohen et al., 2009). 
The actions of multiple neuromodulators may also converge onto a single receptor to 
generate a particular behavior. For example, the neuropeptides FLP-10 and FLP-17 are 
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released from the head sensory neurons and act on the EGL-6 receptor in a motorneuron 
to inhibit egg-laying behavior (Ringstad and Horvitz, 2008). These studies indicate that 
neuromodulators select a subset of neurons from a large network of anatomically-
specified connections. Structurally hardwired circuits have the potential for generating 
different behaviors, but the neuromodulatory state defines which potential is available at 
a given time under a specific set of conditions. Our findings in Chapter II reveal that the 
anatomically defined neural circuit for C. elegans egg-laying is sufficient to promote 
successful deposition of eggs, but neuromodulatory signaling (mediated by the NLP-7 
and FLP-11 neuropeptides) refines activity within the circuit and enables the same circuit 
to adopt distinct functional configurations to generate two opposing behavioral outcomes 
– the active phase and inactive phase. Our results also point towards a specialized role 
for neurosecretory cells as sites for neuromodulator release and demonstrate a local 
requirement of peptide release to alter circuit function and lead to profound changes in 
the timing of a behavioral program.  
 
Future studies on neuromodulation           
 
 Anatomical reconstructions and ultrastructural analyses aimed at understanding 
the full set of neuronal connections and gaining knowledge about the rules for synaptic 
connectivity have proven and will prove invaluable for understanding brain function. There 
is no other way of dissecting the functions of circuits without knowing their connectivity 
diagrams. However, it is not sufficient to interpret differential activity patterns within the 
brain. It would not explain the modifications in circuit composition and dynamics that arise 
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from neuromodulatory actions. Most neuromodulators are non-synaptically released and 
may diffuse over long distances to act on distant targets, thus largely getting ignored in 
the analysis of the connectome. This, coupled to the immense complexity of 
neuromodulatory networks have limited our understanding about neuromodulation at the 
most basic level.  
 Gaining a complete knowledge of brain function will require the connectivity 
diagram that is supplemented with detailed information of all neurotransmitters and 
neuromodulators expressed in each neuron. Identification of their receptors and 
downstream effectors along with a fundamental understanding about their functions will 
also be required. It will be crucial to be able to simultaneously record the electrical 
activities of multiple components within a circuit at a specific modulatory state. 
Computational models would be necessary to understand or predict multiple behavioral 
outputs from single circuits. Finally, it will require the use of suitable model systems where 
in vivo actions of specific neuromodulatory signaling pathways could be correlated with 
behavioral flexibility in the context of the environment and internal modulatory states. 
Elucidating and comparing the general principles of modulation across species would 
potentially lead us to understand the fundamental rules of neuromodulation that govern 
the adaptability of circuits in response to changing contexts.  
 In this dissertation, I demonstrate the in vivo actions of specific neuromodulatory 
systems in shaping alternate behavioral outcomes by studying neuropeptide signaling in 
the context of the relatively simple circuit responsible for C. elegans egg-laying behavior. 
The work presented in Chapter II, demonstrates how neuropeptidergic signaling is 
encoded within a neural circuit under in vivo conditions. It indicates a role for 
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neurosecretory cells (uv1) in locally modulating the activity of motorneurons (HSNs) and 
regulating serotonergic transmission within the circuit. In Chapter II, I also identify the 
molecular candidates (NLP-7 and FLP-11) that mediate the modulatory actions of uv1 
cells and shape the temporal organization of egg-laying by setting the duration of 
quiescent periods (inactive phases) in the behavioral program. In Chapter III, I elucidate 
the potential receptors and downstream signaling components that may be mediating the 
action of the neuropeptides NLP-7 and FLP-11 in modulating circuit activity. This 
dissertation uncovers principles of neuromodulatory actions operating in vivo and links 
them to distinct behavioral outcomes. Understanding the basic rules that govern 
neuromodulation in simple model organisms will significantly contribute towards 
deciphering modulatory principles in more complex circuits and attaining a complete 
knowledge of neural circuit mechanisms underlying distinct behavioral outcomes.     
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Figure IV-1. Genetic interactions between tyramine and neuropeptides. 
Quantification of eggs in utero for the genotypes indicated. tdc-1(lf) and lgc-55(lf) 
mutants fail to enhance the constitutive egg-laying of nlp-7(lf);flp-11(lf) double mutants. 
Bars represent mean ± SEM for each genotype. ** p < 0.01, ns - not significant.   
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Figure IV-2. Possible pathways of NLP-7 mediated inhibition of HSN activity and 
egg-laying behavior. NLP-7 peptides may inhibit HSN activity through EGL-47 that in 
turn, may regulate the activity of chloride channels resulting in chloride influx and 
subsequent hyperpolarization of the HSNs. In a parallel genetic pathway, NLP-7 may bind 
to a yet unknown Gao coupled GPCR and operate through GOA-1 to inhibit serotonin 
release from the HSNs. These two parallel genetic pathways operate redundantly to 
inhibit HSN activity and promote periods of quiescence in the egg-laying behavioral 
program. 
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